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White spot syndrome virus (WSSV) is the most serious pathogen in shrimp 
aquaculture recently. One of the objectives of this study is to apply protein array platform 
for high-throughput screening of WSSV protein functions. Gateway cloning technique 
was applied to construct entry and expression clones of the open reading frames of 
WSSV.  The expressed and purified WSSV recombinant proteins were used to screen 
protein-protein interactions by protein array technology.  
Potential interactions of WSSV proteins with actin, shrimp cytoskeleton and nuclear 
proteins were screened. It was found that wsv006, wsv077, wsv254, wsv407, wsv477 and 
wsv076 interacted with actin. The interaction of wsv006 with actin was confirmed by 
protein overlay assay and the interaction of wsv254 with actin was further confirmed by 
co-immmunoprecipitation. By interacting with actin, both of the structural proteins may 
help the viral nucleocapsid to move toward the host nucleus. Several viral proteins were 
found to interact with shrimp cytoskeleton and nuclear proteins separately by the protein 
array screening. Pull down assay of wsv254, wsv407 with shrimp cytoskeleton proteins 
and wsv254, wsv493 with shrimp nuclear proteins were carried out, but no specific 
binding was found.  
Meanwhile, shotgun proteomics was applied to investigate the WSSV proteome and 
45 viral proteins were identified and 13 of them were reported for the first time.  
Furthermore, 23 envelope proteins and 6 nucleocapsid proteins were identified by iTRAQ 
(isobaric tags for relative and absolute quantification).  Among them, 12 envelope 
proteins and 2 nucleocapsid proteins were identified for the first time. Two novel proteins 
 vii
wsv010 and wsv432 identified in the shotgun proteomics study were shown to be viral 
envelope proteins by Western blot and immunoelectron microscopy.  Furthermore, pull-
down assay revealed that wsv010 could interact with VP24, a major WSSV envelope 
protein.  Previous studies indicated that VP24 could also interact with another two major 
WSSV structural proteins VP26 and VP28. Therefore, we proposed that VP24 may act as 
a linker protein to associate these envelope proteins together to form a complex, which 
may play an important role in viral morphogenesis and viral infection. 
This comprehensive study of WSSV proteins should facilitate the studies of the 
WSSV assembly and mechanism of infection. It should also provide the foundation for 
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1.1 Overview of White Spot Syndrome Virus 
 
1.1.1 Shrimp and Crayfish Viruses 
 
Shrimp aquaculture has been an important industry for several decades in many 
countries worldwide. However, since 1992, shrimp diseases have emerged as a major 
constraint to the continual expansion of this industry. Many diseases are caused by 
environmental deterioration and intensive aquaculture. Among all the pathogens, viruses 
are the biggest threat to the shrimp aquaculture industry.  Roughly 20 shrimp viruses 
have been found in penaeid shrimp (Table 1.1) (Chen, 1997; Lightner, 1998). It should be 
pointed out that systemic ectodermal and mesodermal baculovirus (SEMBV), rod-shaped 
virus of Penaeus japonicus (RV-PJ), white spot baculovirus (WSBV) and hypodermal 
and hematopoietic necrosis baculo-like virus (HHNBV) (Wang, Poulos, and Lightner, 
2000) in Table 1.1 were shown to be WSSV in later studies. Compared with other viral 
pathogens, white spot syndrome virus (WSSV) is the most serious one. It can cause up to 
100 % mortality within 7 to 10 days in commercial shrimp farms (Wang, Poulos, and 
Lightner, 2000), resulting in huge economic losses.  
1.1.2 Characteristics of WSSV 
 
The name of white spot syndrome virus was from the distinctive feature of white 
spots in the cuticle of the acutely infected shrimp (Fig. 1.1) (Kiatpathomchai et al., 2001; 
Wang et al., 1999). The white spots are abnormal deposits of calcium, which probably 
caused by the disruption of exudates transfering from epithelial cells to the cuticle via 




















Fig 1.1 Clinical sign of WSSV in shrimp and crayfish  
 
(A) WSSV infected shrimp with an apparent presence of white spots on the cuticle. 
(B) WSSV experimentally infected crayfish. It was used in our laboratory for virus 







Histopathological features caused by WSSV were first revealed by light 
microscopy observations (Durand et al., 1997; Wang et al., 1999; Wongteerasupaya, 
1995). This virus circulates ubiquitously in the haemolymph of infected shrimp. It infects 
most organs and tissues, except for hepatopancreatocytes and epithelial cells of the 
midgut, which are regarded as refractory tissues (Wang et al., 1999). When the shrimp 
was experimentally infected by WSSV per os, the infected cells were observed first in the 
stomach, gill and cuticular epidermis of the shrimp, and subsequently in other tissues of 
mesodermal and ectodermal origins (Chang, 1996). 
More detailed morphology of WSSV was observed under electron microscopy 
(EM) (Huang et al., 2001). Firstly, it is found that the shape of the virus is from ellipsoid 
to bacilliform. The size of the intact viral particle is approximately 110-130 nm in 
diameter and 260-350 nm in average length. An interesting feature of WSSV is that it 
contains a tail-like appendage at one end of its envelope. The negatively stained intact 
WSSV virions are shown in Figure 1.2. Secondly, the nucleocapsid of the virus, 
consisting of a capsid with the enclosed nucleic acid, is wrapped in the envelope. The 
naked nucleocapsid is about 80×350 nm, and its length is 40 % longer than the intact 
virions (Figure 1.3) (Huang et al., 2001; Leu et al., 2005). A “ring” structure could also 
be seen in some of the degraded viral nucleocapsid. In a recent paper (Leu et al., 2005), 
VP664 has been identified as the largest viral structural protein and is the major 
component of the WSSV nucleocapsid. EM photos showed that the gold particles labeled 
with anti-VP664 polyclonal antibody were regularly distributed around the periphery of 
the nucleocapsid with a periodicity that matched the characteristic stacked ring subunits 
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that appear as striations (Fig 1.4). From this result, the authors hypothesized that VP664 






























Fig 1.2 Negatively stained intact WSSV virions under EM (Huang et al., 2001) 
 
A) Purified WSSV is shown with the Scale Bar=416 nm.  
B) An electron micrograph of a single WSSV virion. Note the long, tail-like 















Fig 1.3 Electron micrographs of purified virions (Leu et al., 2005) 
 
(A) The white outlines indicate (i) a complete mature virion with a characteristic tail, (ii) 
a ruptured mature virion with more than half of the nucleocapsid exposed outside of the 
envelope, and (iii) a completely exposed mature nucleocapsid. (B) Immature, naked 


















Fig 1.4 Immunoelectron microscopy analysis of purified virions probed with VP664 
antibody (Leu et al., 2005) 
 
(A and B) The antibody specifically binds to the nucleocapsid and not to the viral 
envelope. (C) Most of the gold particles are localized to the perimeter of the nucleocapsid. 
(D) Occasionally, the gold particles are localized across the top of a nucleocapsid. (E) A 






1.2 Research Progress of WSSV  
1.2.1 Isolation and Propagation of WSSV 
 
Researchers have previously used shrimp as an experimental host for WSSV 
infection. However the shrimps are hard to maintain and this practice is expensive. Until 
2001, a very efficient virus purification system was established (Huang et al., 2001). In 
this system, crayfish, Cambarus clarkii was used as the host for WSSV infection and 
purification, which enables researchers to obtain sufficient quantities of WSSV for 
further analysis. 
1.2.2 Complete Genomic Study of WSSV 
 
The whole genome of WSSV was sequenced by three groups separately using 
viruses isolated from China, Thailand and Taiwan, respectively (Genebank Accession 
Nos. AF332093, AF369029, AF440570) (Chen et al., 2002; van Hulten et al., 2001; Yang 
et al., 2001). The complete WSSV genome is a double-stranded circular DNA of 
305,107 bp. The start of the largest BamHI fragment was chosen to be base 1 because the 
origin of replication was unknown. Nine homologous regions (hrs) constitute three 
percents of the WSSV genome, while the remaining 97 % of the sequences are unique. 
The genome has a total 41 % of uniformly distributed G+C content (Yang et al., 2001). 
531 putative open reading frames (ORFs) were identified by sequence analysis. Among 
these ORFs, 181 of them are non-overlapped and encode potential functional proteins 
with 60 or more amino acids. The relative positions of the ORFs and hrs in the genome 
are shown in Fig 1.5. Eighty percent of the 181 ORFs have a potential polyadenylation 
site (AATAAA) downstream of the ORFs. Among the 181 ORFs, 18 ORFs encode 
putative proteins showing 40 to 68 % identity to known proteins from other viruses or 
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organisms or contain an identifiable functional domain. Predicted proteins of 30 ORFs 
also show 20 to 39 % homology to known proteins or contain one or two sequence motifs. 
However, the remaining 133 ORFs encode novel proteins with no homology to any 
known proteins or motifs (Yang et al., 2001). Based on the studies of individual WSSV 
genes and analysis of the complete genome sequence, it has been designated as a new 
virus family, the Nimaviridae  (http://www.ncbi.nlm.nih.gov/ICTVdb/Ictv/index.htm). 
1.2.3 Proteomics Study of WSSV 
The first proteomics study identified 18 structural proteins of WSSV using one 
dimensional (1D) sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) and matrix-assisted laser desorption ionization–time of flight (MALDI-TOF) or 
electrospray ionization tandem mass spectrometry (ESI-MS/MS) utilizing a quadrupole 
time-of-flight (Q-TOF) mass spectrometer (Huang et al., 2002b). Seven more proteins 
were found by two-dimensional gel electrophoresis and mass spectrometry (Zhang et al., 
2004). Recently, 33 of WSSV structural proteins resolved by 1D SDS-PAGE were 
identified using the on-line liquid chromatography (LC)-ESI Q-TOF mass spectrometer 
(Tsai et al., 2004). All these work contribute to the knowledge of WSSV structural 
proteins. A total of 38 proteins were identified by these three proteomics studies. Most 
recently, 11 additional WSSV proteins were identified for the first time in infected 
shrimp epithelium by shotgun proteomics and were tentatively postulated as potential 
candidates of non-structural proteins (Wu et al., 2007).  
1.2.4 Localization of Structural Proteins in the WSSV Virion 
Immunogold electron microscopy (IEM) is a classic technique to identify protein 








Fig 1.5 Circular representation of the WSSV genome (Yang et al., 2001) 
Arrows, positions (outer ring) of 181 ORFs (red and blue indicate the different directions 
of transcription); green rectangles, 9hrs.  B, sites of BamHI restriction enzymes (inner 






by IEM technique (Leu et al., 2005; Li, Xie, and Yang, 2005; Xie, Xu, and Yang, 2006; 
Zhang et al., 2002; Zhu, Li, and Yang, 2006). A more systematic study on WSSV 
structure proteins was done recently with Western-blot technology and mass 
spectrometry. Seven envelope proteins, 5 tegument proteins and 4 nucleocapsid proteins 
were identified by Western-blot analysis and 2 additional nucleocapsid proteins by mass 
spectrometry (Tsai et al., 2006). To date, the localization of 27 proteins in the virion has 
been determined among the known structural proteins. 
1.2.5 Structural Study of WSSV 
Most recently, crystal structure of the two major envelope proteins VP26 (wsv311) 
and VP28 (wsv421) from WSSV were resolved at 2.2 and 2.0 Å respectively  (Tang et al., 
2007). It was reported that both proteins adopt β-barrels architecture with a protruding 
region. The spike-like structure of VP26 and VP28 observed in the immuno-electron 
microscopy images matches well with the trimeric shape of the crystal structure. Based 
on this structural study, the authors proposed that VP26 and VP28 may anchor on the 
viral envelope membrane via their predicted N-terminal transmembrane regions, while 
leaving the core β-barrel to protrude outside the envelope to interact with the host 
receptor or to fuse with the host cell membrane for effective viral infection. Meantime, 
the structure of VP9 (wsv230) was also determined by both X-ray and nuclear magnetic 
resonance (NMR) techniques (Liu et al., 2006). The crystal structure of VP9 revealed a 
ferredoxin fold with divalent metal ion binding sites and NMR metal titration data 
indicated that VP9 bind with both Zn2+ and Cd2+. It was also found that VP9 adopted a 
similar fold as the DNA binding domain of the E2 protein from human papillomavirus. 
Based on these investigations, the authors hypothesize that VP9 might be involved in the 
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transcriptional regulation of WSSV, a function which is similar to the E2 protein during 
papillomavirus infection of the host cells.  
1.2.6 Functional Study of WSSV 
According to the WSSV genome study, only ~30 % of the WSSV ORFs have 
putative homologues to any known proteins or motifs and most of them encode enzymes 
for nucleotide metabolism, DNA replication, and protein modification (van Hulten et al., 
2001; Yang et al., 2001). Until now, only a limited number of proteins have been studied. 
Firstly, both the large and the small subunits of ribonucleotide reductase wsv172 and 
wsv188 were found to be early transcribed, located in proximity on the WSSV genome, 
and characterized by enzyme activity assay (Lin et al., 2002; Tsai et al., 2000a). Secondly, 
a chimeric protein wsv395 consisting of a thymidine kinase (TK) and thymidylate kinase 
(TMK) was found to be a unique feature of WSSV, as it is normally encoded by separate 
ORFs in other large DNA viruses (Tsai et al., 2000b). Thirdly, a putative non-specific 
nuclease wsv191 was found to have the nuclease activity (Li, Lin, and Yang, 2005). 
Fourthly, a potential protein kinase wsv423 was also revealed on gene level (Liu et al., 
2001). It does not have any close relatives and does not fall into any of the major protein 
kinase groups.  Another specific feature of WSSV is that it has an intact collagen gene 
wsv001, which was found in a virus genome for the first time (Li, Chen, and Yang, 2004). 
Although some of the work is still preliminary, these functional studies will provide 
information for studying the virus infection mechanism. 
For the virus protein-protein interactions, it was reported that structural protein 
VP24 interacts with major structural proteins VP28 and VP26  forming a complex to 
participate in virus infection together (Le et al., 2005).  For the virus host protein 
 15
interactions, VP26 was reported to be capable of binding to actin or actin-associated 
proteins (Xie and Yang, 2005). Another structural protein VP281, with a cell attachment 
Arg-Gly-Asp (RGD) motif, was also reported to play an important role in mediating 
WSSV infectivity (Huang et al., 2002a; Liang et al., 2005). Recently, PmRab7 was 
identified as a binding partner of VP28 during the virus infection (Sritunyalucksana et al., 
2006). 
However, the above listed work are only related to one or several specific genes, 
most of the putative ORFs identified on the WSSV genome are still unassigned, as they 
lack homology to any known genes in public databases. A comprehensive and systematic 
function study is therefore necessary for further understanding the mechanism of this 
virus infection. Compared with the study on WSSV, less work have been done on the 
defense mechanism of the host against WSSV infection. And to understand WSSV 
infection mechanism, it is very important to study the interaction of virus proteins with 
host proteins.  
1.3 Approaches for WSSV Functional Study  
1.3.1 Gateway Technology 
Recognizing all these problems, it is important to study the functions of the 
WSSV proteins in a high-throughput format. The first requirement is to clone all the 
WSSV ORFs, and then to over-express and purify their corresponding proteins. Gateway 
technology was chosen in this study to construct WSSV expression clones. Based on the 
site-specific recombination properties of bacteriophage lambda, Gateway technology 
enables the transfer of DNA segments among different vectors while maintaining 
orientation and reading frame (Hartley, Temple, and Brasch, 2000; Palzkill, 2002; 
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Walhout et al., 2000) Without the use of restriction endonucleases and ligase, it 
eliminates many time-consuming cloning and subcloning steps. It has been applied in 680 
scientific papers (http://www.invitrogen.com/downloads/GatewayCitation2005) 
published in 2005. Gateway technology provides a rapid and highly efficient way to 
move DNA sequences into multiple vector systems for functional analysis and protein 
expression. It also provides the following advantages: permits the use and expression 
from multiple types of DNA sequences (e.g. PCR products, cDNA clones, restriction 
fragments); easily accommodates the transfer of a large number of DNA sequences into 
multiple destination vectors; suitable for adaptation to high-throughput formats; allows 
easy conversion of the favorite vector into a Gateway destination vector. Two 
recombination reactions constitute the basis of the Gateway Technology (Fig 1.6). 
BP Reaction: Facilitates recombination of an attB substrate (attB-PCR product) 
with an attP substrate (donor vector) to create an attL-containing entry clone. 
LR Reaction: Facilitates recombination of an attL substrate (entry clone) with an 






























Fig 1.6 Gateway recombination reactions 
 
 
attB, attP, attL, and attR are the recombination sites 
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1.3.2 Protein Array Technology 
Protein array is an emerging technology that allows high-throughput screening of 
protein functions including protein-protein interactions (Cahill, 2001; Lee and Mrksich, 
2002; Palzkill, 2002; Wang et al., 2006; Zhu et al., 2001). With protein array, the 
biochemical activities of proteins can be systematically analyzed by probing proteins in a 
high-throughput fashion. Another advantage of protein array is that it is very sensitive 
and only requires a small quantity of protein in each assay.  
Currently, there are mainly two classes of protein arrays: analytical and functional 
protein arrays (David A. Hall, 2007; LaBaer and Ramachandran, 2005). Most of 
analytical protein arrays are antibody microarrays, which have become one of the most 
powerful multiplexed detection technologies. Analytical microarrays are typically used to 
profile a protein mixture in order to measure binding affinities, specificities, and protein 
expression levels of the proteins in the mixture. In this technique, a library of antibodies 
is arrayed on a glass microscope slide and then probed with a protein solution. It can be 
used to monitor differential expression profiles and for clinical diagnostics. Examples 
include profiling responses to environmental stress, and healthy versus disease tissues. 
Functional protein arrays are composed of arrays containing full-length functional 
proteins or protein domains. These protein arrays are used to study the biochemical 
activities of an entire proteome in a single experiment. They are used to study numerous 
protein interactions, such as protein–protein, protein–DNA, protein–phospholipid, and 
protein–small molecule interactions (Fig 1.7) (Zhu and Snyder, 2003). An example of 




Fig 1.7 Applications of protein microarrays (Zhu and Snyder, 2003)  
There are two general types of protein microarray: analytical and functional protein 
microarrays. Analytical microarrays involve a high-density array of affinity reagents (e.g. 
antibodies or antigens) that are used for detecting proteins in a complex mixture. 
Functional protein chips are constructed by immobilizing large numbers of purified 
proteins on a solid surface. Unlike the antibody–antigen chips, protein chips have 
enormous potential in assaying for a wide range of biochemical activities (e.g. protein–
protein, protein–lipid, protein–nucleic-acid, and enzyme–substrate interactions), as well 
as drug and drug target identification. Small molecule and carbohydrate microarrays are 
other types of analytical microarrays that have been demonstrated to be capable of 









Fig1.8 Examples of different assays using protein array (Zhu et al., 2001) 
Proteome chips containing 6566 yeast proteins were spotted in duplicate and incubated 
with the biotinylated probes indicated. The positive signals in duplicate (green) are in the 
bottom row of each panel; the top row of each panel shows the same yeast protein 
preparations of a control proteome chip probed with anti-GST (red). The upper panel 







Typically, protein chips are prepared by immobilizing proteins onto a treated 
microscope slide using a contact spotter or a non-contact microarrayer. A number of 
different slide surfaces can be used for protein arrays. A qualified slide surface should be 
able to immobilize the protein, maintain the conformation and the functionality of the 
protein, and achieve maximum binding capacity (Zhu and Snyder, 2003). In the first 
protein array paper, aldehyde glass slide was used for random protein attachment through 
amines (MacBeath and Schreiber, 2000), Affinity tag surface has the advantage for the 
uniform orientation of proteins on the chip surface. One popular choice is the nickel 
coated slide for the use with HisX6 tagged proteins (Zhu et al., 2001). Another one is 
streptavidin coated slides (Lesaicherre et al., 2002), which is an ideal choice for binding 
biotinylated proteins.  
When the proteins are immobilized on the slides, they can be probed for a variety 
of functions and activities. The probes may be labeled with either fluorescent, affinity, 
photochemical, or radioisotope tags. Fluorescent labels are generally preferred, as they 
are safe and effective and are compatible with microarray laser scanners. Moreover, 
probes can also be labeled with affinity tags or photochemical tags (Mitsopoulos, Walsh, 
and Chang, 2004). Label-free detection methods also have been developed to allow for 
the collection of kinetic binding data recently (Ramachandran et al., 2006).  
1.3.3 Common Techniques for Protein-Protein Interaction Studies  
 
After obtaining protein-protein interaction data from protein array work in a high-
throughput format, it is necessary to use other protein-protein interaction methods to 
confirm the protein array results.  




Protein overlay assay is a useful method for studying protein-protein interactions. 
It involves the fractionation of proteins on SDS-PAGE, blotting to nitrocellulose 
membrane, and incubation with a probe of interest (Huelseweh, Ehricht, and Marschall, 
2006). Many different kinds of protein-protein interactions can be studied via protein 
overlay assay,  including screens for unknown protein-protein interactions as well as 
detailed characterization of known interactions (Chu and Ng, 2003). When the protein 
overlay assay is detected by incubation with an antibody, it is usually called “Far Western 
blot”, as it is very similar to the Western blot method. The protein overlay assay can also 
be detected with streptavidin if the probe is biotinylated or with autoradiography if the 
overlaid probe is radiolabeled. 
1.3.3.2 Pull Down Assay 
The pull-down assay is an in vitro method used to determine protein-protein 
interactions (Schechtman, Mochly-Rosen, and Ron, 2003). It is very useful for both 
confirming the existence of a protein-protein interaction predicted by other techniques 
and as an initial screening assay for identifying previously unknown protein-protein 
interactions. The minimal requirement for a pull-down assay is the availability of a 
purified and tagged protein (the bait) which will be used to ‘pull-down’ a protein-binding 
partner (the prey). In a pull-down assay, a purified tagged bait protein is captured on an 
immobilized affinity ligand specific for the tag. This immobilized bait protein can then be 
incubated with a variety of other protein sources that contain putative prey proteins. The 
interacting proteins are usually determined by unique protein bands isolated from a 
polyacrylamide gel followed by mass spectrometric identification. 
1.3.3.3 Co-immunoprecipitation  
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Co-immunoprecipitation is another classical technique used to determine protein-
protein interactions (Basmaciogullari et al., 2006). It involves the interactions between a 
protein with its specific antibody and its interacting protein partners. This technique 
provides a rapid and simple means to separate a specific protein from whole cell lysates 
or culture supernatants. The abundance of a given protein in a sample is a critical factor 
for obtaining desired results. The success of immunoprecipitation also depends on the 
affinity of the antibody for its antigen as well as for Protein G or Protein A.  
1.3.4 Proteomics Approaches 
As a rapidly growing area of biology, proteomics is the platform technology for 
the systematic, large-scale analysis of proteins. Proteomics is seen as a mass-screening 
approach to molecular biology with the aims to document the overall distribution of 
proteins in cells, to identify and characterize individual proteins of interest, and 
ultimately to elucidate their functional relationships (Twyman, 2004). The analysis of a 
proteome mainly requires the technologies of separating and identifying protein. For the 
separation technique, it should produce fractions that comprise very simple mixtures of 
proteins in a high-throughput format. Furthermore, it should be compatible with 
downstream protein identification analysis. Two-dimensional gel electrophoresis (2DGE) 
and liquid chromatography (LC) are the two techniques that dominate proteomics. 1DGE 
is also suitable for the separation of viral protein mixtures that are relatively less complex 
than the protein mixtures of eukaryotic cells. Our previous study on Singapore grouper 
iridovirus suggested that the 1DGE approach and the LC-based shotgun approach are 
equally effective and complementary to each other (Song et al., 2006). 1DGE and 2DGE 
approaches have been applied in WSSV proteomics studies (Huang et al., 2002b; Tsai et 
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al., 2004; Xie, Xu, and Yang, 2006; Zhang et al., 2004). In this study, we applied shotgun 
proteomics, which involves direct digestion of total proteins to complex peptide mixtures, 
followed by the automated identification of the peptides.  
For the identification of the peptides, mass spectrometry is the major technology 
platform for high-throughput protein identification (Pandey and Mann, 2000). Mass 
spectrometry provides extremely sensitive measurements of the mass of molecules and 
this data can be used to search protein and nucleotide databases to identify a protein 
(Wilm and Mann, 1996). Mass spectrometry relies on the digestion of the proteins into 
peptides by a sequence specific protease such as trypsin. A mass spectrometer consists of 
three principal components: an ionization source, a mass analyzer and an ion detector 
(Palzkill, 2002). The function of the ionization source is to convert the analyte into gas 
phase ions in a vacuum. The mass analyzer uses a physical property such as time-of-
flight (TOF) to separate ions of a particular m/z value that then strike the detector. The 
detector produces a magnitude of the current that is used to determine the m/z value of 
the ion.   
Matrix-assisted laser desorption ionization (MALDI) creates ions from the energy 
of a laser with an energy absorbing matrix (Cotter, Fancher, and Cornish, 1999). This 
method of ionization is often used in conjunction with time-of-flight detection (MALDI-
TOF) to identify proteins by peptide mass fingerprinting (Henzel et al., 1993). Tandem 
mass spectrometry (MS/MS) is another approach used for protein identification.  This 
instrument consists of an ion source, a first mass analyzer, a gas-phase collision cell, a 
second mass analyzer and an ion detector. The first mass analyzer is used to resolve the 
peptides in the mixture and isolate one particular peptide at a time to send to the collision 
 25
cell. The mass of the spectrum of fragments is determined in the second mass analyzer 
and is diagnostic of the amino acid sequence of the peptide. The major advantage of the 
tandem mass spectrometry compared to MALDI peptide fingerprinting is that the 
sequence information obtained from the peptides is more specific for the identification of 
a protein than simply determining the mass of the peptides.  
In this study, quantitative proteomics using isobaric tags for relative and absolute 
quantification (iTRAQ) was employed to distinguish envelope proteins and nucleocapsid 
proteins of WSSV.  It is a newly developed LC-based quantitative proteomic approach, 
which allows for comparison of up to four different samples simultaneously (Ross, 2004). 
It has been successfully applied to measure the enrichment of organelle proteins (Chen et 
al., 2006) and the protein correlation profiling (Foster et al., 2006).   
The iTRAQ reagents were designed as isobaric tags consisting of  a peptide 
reactive group, a neutral balance portion, and a charged reporter group that is unique to 
each of the four reagents (Fig 1.9) (Zieske, 2006). These 4 reagents, upon MS/MS 
fragmentation give rise to four unique reporter ions (m/z=114, 115, 116, 117) that are 
used to quantify their respective samples. The peptide reactive group was designed to 
react with all primary amines to label all peptides in up to four different biological 
samples thus enhancing peptide coverage for any given protein. The mass shift imposed 
by each reported group is balanced with a balance group, such that the total mass of each 
of the four tags is identical. Thus any given peptide labeled with each of the four tags has 
the same mass.  
The general workflow of iTRAQ is depicted in Fig 1.10 for four different samples. 
Each individual sample is reduced, alkylated, and digested with trypsin. The resulting 
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peptide mixtures are then labeled with one member of the iTRAQ reagents, respectively 
(Zieske, 2006). With isobaric peptides, the MS ion current at a given peptide mass is the 
sum of ion current from all samples in the mixture, so there is no increase in spectral 
complexity by combining two or more samples. But the peptides will show intense low-






























Fig 1.9 The iTRAQ reagents (Zieske, 2006) 
The iTRAQ reagent was designed as an isobaric tag consisting of a charged reporter 
group, a peptide reactive group, and a neutral balance portion to maintain an overall mass 
of 145. (Isobaric, by definition, implies that any two or more species have the same 

















Fig 1.10 The general workflow of iTRAQ (Zieske, 2006) 
General scheme of a multiplex reaction of four different samples (S1–S4), designated by 









1.4 Objectives of the Study  
All the ORFs of WSSV genome will be cloned using the Gateway expression 
system in a high throughout format and the proteins will be expressed. With the purified 
proteins, protein array of WSSV proteins will be developed to analyze virus protein-
protein interactions, virus-host protein-protein interactions. Common methods for 
studying protein-protein interactions, such as protein overlay assay, pull down and co-
immunoprecipitaion will also be used to study the protein-protein interactions and to 
confirm the protein array results. Shotgun proteomics and iTRAQ technology will be 
applied to study WSSV structural proteins. 
1.5 Significance of the Study 
Through these experiments, we hope to find out which proteins are important for 
virus assembly, replication and to identify the virus-binding host proteins. It may lead to 
the development of inhibitors of virus entry, replication, transcription, movement or 
transmission. All these works should contribute to the development of antiviral drugs and 
vaccines, which will definitely benefit the devastated shrimp farming industry. 
1.6 Scope of the Study 
1. To study protein-protein interactions by protein array technology and 
routine protein-protein interaction methods including protein overlay 
assay, pull down assay and co-immunoprecipitaion technology. 












































Constructing WSSV entry and expression clones is the first step for the whole 
study. Gateway system was applied to construct the clones as it has the advantages 
highlighted in Chapter 1.  
2.2 Material and Methods 
 
2.2.1 Extraction of WSSV Genomic DNA  
Firstly, WSSV genomic DNA was extracted from purified virus (China isolate 
and the genome accession number is AF332093) by protease K and 
cetyltrimethylammonium bromide (CTAB) treatments, followed by phenol-chloroform 
extraction, and ethanol precipitation (Lo et al., 1996; Yang et al., 2001). Protease K and 
N-laurysarcosine were added to the purified viral particles suspended in TNE buffer (10 
mM Tris, 0.2 M NaCl, 1 mM EDTA, pH 7.4) to a final concentration of 0.5 mg/ml and 
0.5 % respectively. After 1 hour incubation at 65 °C, the sample was treated with 1 % 
CTAB for 15 mins at 65 °C and followed by extractions with an equal volume of phenol 
once, an equal volume of phenol:chloroform:isoamyl alcohol (25:24:1) 3 times, an equal 
volume of chloroform:isoamyl alcohol once. The viral DNA was recovered by ethanol 
precipitation, dried and dissolved in a small volume of TE buffer (50 mM Tris, 1 mM 
EDTA,  pH8.0) plus RNAse A (10 ug/ml), and then quantified by spectrophotometer with 
the Shimadzu spectrophotometer (Model UV-300). 
 
2.2.2 Producing attB-PCR Products of WSSV ORFs 
 
2.2.2.1 Design of WSSV attB PCR Primers 
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To enable efficient Gateway cloning, the forward primer must contain the 
following structure: Four guanine (G) residues at the 5′ end followed by 25 bp attB1 site 
and 18-25 bp of gene-specific sequences. For the reverse PCR primer, it must contain the 
following structure: Four guanine (G) residues at the 5′ end followed by 25 bp attB2 site 
and 18-25 bp of gene-specific sequences.  
AttB1 Forward primer: 
 
5’ –GGGG-ACA-AGT-TTG-TAC-AAA-AAA-GCA-GGC-TNN-(gene specific 
sequence)-3’ 
AttB2 Reverse primer: 
 
5’ –GGGG-AC-CAC-TTT-GTA-CAA-GAA-AGC-TGG-GTN-(gene specific 
sequence)-3’  
 
2.2.2.2 Amplifying attB-PCR Products 
 
The WSSV genomic DNA extracted from purified virus was used as the DNA 
template and high fidelity Pfu DNA polymerase (Promega) was used to amplify the 
ORFs. The composition of PCR reaction mixture was listed below: 5 µl 10 × PCR buffer 
(without MgCl2), 5 µl MgCl2 (25 mM), 1 µl 5’ Primer (10 µm), 1 µl 3’ Primer (10 µm), 1 
µl dNTPs (2.5 mM) l, 1 µl Template DNA (20-100 ng/ µl), 1 µl  Pfu DNA polymerase (1 
unit/ µl) and distilled water to a final volume of 50 µl. The PCR reaction was run on an 
iCycler Thermal Cycler (Bio-rad) with the following program: 1 cycle at 95 °C for 1 ~ 2 
mins, 30 cycles of each at 95 °C for 30 seconds, 50 °C for 30 seconds, 72 °C for 1 min 
per 1kb DNA fragment and 1 cycle of 72 °C for 15 mins.   




After PCR reaction, the DNA fragments were separated by agarose gel 
electrophoresis in TAE buffer (0.04 M Tris-acetate, 0.001 M EDTA, pH 8.0). Usually, 
the concentration of agarose gel is 1 % and ethidium bromide (EB) was added with a 
final concentration of 0.5 µg/ml. QIAquick PCR Purification Kit (QIAGEN) was used to 
purify the PCR products. Firstly, 5 volumes of Buffer PB were added to 1 volume of the 
PCR sample and mixed. Then the sample was applied to the QIAquick column. The 
column was centrifuged at 15,000 x g in a conventional tabletop microcentrifuge for 30–
60 seconds and the flow-through was discarded. The column was washed with 0.75 ml 
Buffer PE and centrifuged again for 30–60 seconds.  The flow-through was discarded and 
the column was centrifuged for 1 min additionally. To elute DNA, 50 µl Buffer EB (10 
mM Tris·Cl, pH 8.5) was added to the center of the QIAquick membrane and the column 
was centrifuged for 1 min.  
2.2.3 Construction of WSSV Entry Clones 
2.2.3.1 Preparation of E.coli Competent Cells 
 
To complete a successful transformation, highly efficient competent cells must be 
prepared firstly. In our lab, the competent cells of E. coli DH5α were prepared by the 
rubidium chloride method. Freshly grown E. coli colony from LB agar plate was 
inoculated into 10 ml of Luria broth (LB) liquid media (10 g tryptone, 5 g yeast extract, 
10 g NaCl, pH 7.5) and cultured overnight at 37 °C. The 10 ml overnight culture was 
then inoculated into conical flask containing 1 liter of LB medium and allowed to grow at 
37 °C with vigorous shaking (200 rpm). After the cells grew to OD550 of 0.45-0.5, the 
culture was chilled on ice for 15 mins and then the cells were collected by centrifugation 
at 3840 × g (Beckman J2-21) for 5 mins at 4 °C. The cell pellet was resuspended in 400 
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ml of ice-cold TfbI buffer (30 mM potassium acetate, 100 mM rubidium chloride, 10 mM 
CaCl2, 50 mM MgCl2, 15 % v/v glycerol, pH 5.8) and incubated on ice for 15 mins. After 
centrifugation at 3840 × g for 5 mins at 4 °C , the cell pellet was resuspended by 40 ml 
TfbII buffer (10 mM MOPS, 10 mM rubidium chloride, 75 mM CaCl2, 15 % v/v glycerol, 
pH 6.5). If not use immediately, the competent cells were frozen in 0.25 - 0.5 ml aliquot 
with liquid nitrogen prior to storage in a -80 °C freezer. 
2.2.3.2 BP Recombination Reaction  
 
The BP recombination reaction facilitates transferring attB-PCR products to an 
attP-containing donor vector to create an entry clone. Once an entry clone is created, the 
gene of interest may be easily transferred into a large selection of expression vectors by 
the LR recombination reaction. The BP recombination reaction mixture contained: 1-7 µl 
AttB-PCR product (final amount 15-150 ng), 1 µl donor vector (150 ng/µl), 2 µl BP 
Clonase™ II enzyme mix, and TE buffer (pH 8.0) to a final volume of 10 µl. The 
reaction mixture was mixed well and incubated at 25 °C for 1-16 h. Proteinase K solution 
was added to the mixture to terminate the reaction. The reaction mixture was vortexed 
briefly and incubated at 37 °C for 10 mins.  The BP recombination reaction product was 
added into a sterile 1.5 ml microcentrifuge tube containing 100 µl of DH5α competent 
cells and mix gently. After incubation on ice for 30 mins, the mixture was heat-shocked 
at 42 °C for 45 seconds and immediately chilled on ice for 2 min. Eight hundred 
microliters of fresh LB medium was added to the tube containing transformed cells and 
the tube was incubated at 37 °C with shaking for 45 min. The cells were collected by 
centrifugation and spread onto LB agar plates containing antibiotic (50 ug/ml kanamycin). 
The plates were incubated at 37 °C overnight.  
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2.2.3.3 Entry Clones Sequencing 
The entry clones generated by BP recombination reaction were screened by PCR 
and sequencing. The sequencing PCR run mixture contained: 2 µl BigDyeTM Ready Mix 
(v 3.0), 3.2 µl M13 Forward primer (1µm): 5′-GTAAAACGACGGCCAG-3′ or M13 
Reverse primer (1µm): 5′-CAGGAAACAGCTATGAC-3′, 2 µl template DNA (purified 
plasmids, 100~200 ng/µl) and 9.8 µl deionized water, totally 20 µl (for ORFs longer than 
1000 bp, sequencing primers based on the ORF sequence were designed for sequencing 
except using M13 forward and reverse primers). The cycle sequencing was normally 
performed using the following program: 1 cycle of 96 °C for 0.5 - 1 min, then 25 cycles 
of 96 °C for 15 seconds, annealing at 50 °C for 15 seconds and extension at 60 °C for 4 
mins, keep at 4 °C until ready to purify. After the cycle sequencing was finished, the 
contents in the PCR tube were spun down and then transferred into a clear 1.5 ml tube. 
Eighty microliters of the mixture (3 µl of 3 M sodium acetate, 62.5 µl 95 % ethanol and 
14.5 µl water) was added to each tube. The contents in the tube were mixed by vortexing 
and the tube was allowed to stand at room temperature for 15 mins to precipitate the 
extension products. The pellet was collected by centrifugation at 18,000 × g (Eppendorf 
5417C) for 20 mins. The pellet was washed with 70 % ethanol twice and then centrifuged 
at 18,000 × g (Eppendorf 5417C) for 10 mins. After the supernatants were carefully 
aspirated from the tube, the pellet was dried and stored at –20 °C. This pellet was ready 
for electrophoresis running. 
2.2.4 Construction of WSSV Expression Clones 
After generating the entry clones, the LR recombination reaction was performed 
to transfer the gene of interest into an attR-containing vector to create an expression 
clone. The expression vector used for E. coli expression system were modified pET32a 
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vectors containing N-terminal avi-tag and C-terminal 6x His tag (pET32a-AH) or N-
terminal 6x His tag and C-terminal avi-tag (pET32a-HA). The LR recombination reaction 
mixture contained: 1-7 µl entry clone (50-150 ng), 1 µl expression vector (150 ng/µl), 2 
µl LR Clonase™ II enzyme mix, and TE buffer (pH 8.0) to a final volume of 10 µl. The 
reaction mixture was mixed well and incubated at 25 °C for 1-16 h. Proteinase K solution 
was added to the mixture to terminate the reaction. The reaction mixture was vortexed 
briefly and incubated at 37 °C for 10 mins.  The LR recombination reaction product was 
added into a sterile 1.5 ml microcentrifuge tube containing 100 µl of DH5α competent 
cells and mix gently. The transformation of competent cells was same as indicated for the 
BP reaction, except using the LB plates containing ampicillin (100 ug/ml). 
2.3 Results 
 
2.3.1 Producing attB-PCR Products of WSSV ORFs 
Based on the established WSSV ORF database in our laboratory, attB-PCR 



































Table 2.1 WSSV ORF database in our laboratory 
 
 
Name Amino acids Base pairs MW (Da) 
wsv001 1684 5064 168454.579 
wsv002 208 627 23146.24 
wsv004 104 315 12208 
wsv006 295 888 32748.61 
wsv008 204 615 20581.9 
wsv009 95 288 11044.93 
wsv010 97 294 11116.5 
wsv011 1301 3906 143897.56 
wsv013 80 243 8612.31 
wsv020 117 354 12491.195 
wsv021 200 603 22788.11 
wsv022 61 186 6658.39 
wsv023 286 861 31459.02 
wsv025 231 696 26378.85 
wsv026 1535 4608 172090.38 
wsv035 972 2919 108366.53 
wsv037 1280 3843 143591.54 
wsv041 60 180 6967.75 
wsv045 981 2946 109316.58 
wsv047 120 363 14343.26 
wsv049 205 618 22221.64 
wsv051 196 591 22504.96 
wsv053 81 246 9075.567 
wsv055 63 192 7000.591 
wsv056 226 681 25664.97 
wsv059 208 567 24534.9 
wsv063 248 747 27989.32 
wsv064 594 1785 68069.86 
wsv065 76 231 8980.88 
wsv067 289 870 33077.48 
wsv069 224 675 25014.01 
wsv073 422 1269 47241.64 
wsv076 276 831 31532.179 
wsv077 297 894 33122.6 
wsv078 398 1197 44596.91 
wsv079 511 1536 57359.03 
wsv083 581 1746 66440.65 
wsv091 1145 3438 125972.17 
wsv097 99 300 11215.13 
wsv100 624 1875 69352.53 
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wsv107 103 312 11498.49 
wsv108 406 1221 43479 
wsv112 461 1386 52424.18 
wsv115 968 2907 108200.32 
wsv119 1044 3135 117923.57 
wsv128 370 1113 42428.36 
wsv129 357 1074 39112.77 
wsv130 150 453 16640.99 
wsv131 484 1455 52903.31 
wsv133 271 816 30746.85 
wsv134 222 669 24992.65 
wsv136 128 387 14535.677 
wsv137 337 1014 38467.78 
wsv139 1208 3627 137836.12 
wsv140 213 642 22700.48 
wsv142 137 414 15800.056 
wsv143 2313 6942 259269.41 
wsv146 66 201 7080.554 
wsv147 459 1380 51926.34 
wsv150 305 918 36334.017 
wsv151 1436 4311 160823.87 
wsv161 759 2280 84943.47 
wsv166 1072 3219 122124.22 
wsv172 848 2547 95599.6 
wsv177 106 321 12417.75 
wsv178 302 909 35367.33 
wsv179 221 663 25777.51 
wsv181 372 1119 43236.71 
wsv184 541 1626 62866.12 
wsv188 413 1242 47560.75 
wsv191 311 936 35487.995 
wsv192 1019 3060 116738.937 
wsv195 257 774 29415.82 
wsv196 61 186 6453.161 
wsv198 278 837 31371.781 
wsv199 856 2571 98112.446 
wsv206 204 615 23194.751 
wsv207 275 828 31914.662 
wsv209 1606 4821 174137.889 
wsv214 80 243 9148.231 
wsv216 1194 3585 131890.38 
wsv220 674 2025 76177.949 
wsv221 269 810 29588.838 
wsv222 844 2535 96977.353 
wsv226 930 2793 106955.976 
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wsv230 82 249 9205.516 
wsv231 615 1848 71349.025 
wsv234 294 885 34013.494 
wsv235 67 204 7631.141 
wsv236 77 234 8662.177 
wsv237 292 879 33164.71 
wsv238 486 1461 51431.533 
wsv242 300 903 34370.315 
wsv244 791 2376 89903.815 
wsv249 783 2352 88762.817 
wsv252 501 1506 56415.075 
wsv254 281 846 31539.764 
wsv256 384 1155 43138.192 
wsv259 309 930 35409.047 
wsv260 922 2769 102997.991 
wsv267 281 846 31185.631 
wsv269 489 1470 56301.684 
wsv270 170 513 19728.241 
wsv271 1218 3657 134435.705 
wsv277 791 2376 87354.04 
wsv282 634 1905 70079.837 
wsv284 100 303 11074.588 
wsv285 1100 3303 123333.031 
wsv289 1565 4698 174467.312 
wsv291 85 258 9289.458 
wsv293 60 183 6563.401 
wsv294 206 621 23473.98 
wsv295 209 630 22469.448 
wsv299 309 930 34334.005 
wsv302 189 570 21230.592 
wsv303 891 2676 100414.948 
wsv305 109 330 12465.798 
wsv306 419 1260 47440.548 
wsv308 466 1401 51875.2 
wsv310 272 819 31369.105 
wsv311 204 615 22152.659 
wsv313 1180 3543 132068.318 
wsv321 117 354 13123.898 
wsv322 227 684 25751.181 
wsv323 88 267 10135.982 
wsv324 82 249 9257.6 
wsv325 465 1398 51038.963 
wsv327 856 2571 96064.367 
wsv331 71 216 7850.21 
wsv332 786 2361 87578.7 
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wsv333 68 207 7676.974 
wsv338 433 1302 48187.088 
wsv339 283 852 32013.991 
wsv340 261 786 29825.709 
wsv342 100 303 11590.594 
wsv343 4180 12543 467143.095 
wsv344 99 300 10949.71 
wsv349 90 273 10121.976 
wsv360 6077 18234 663770.555 
wsv386 68 207 6760.598 
wsv387 729 2190 85062.325 
wsv388 78 237 8772.617 
wsv390 321 966 35812.243 
wsv394 101 306 11913.991 
wsv395 398 1197 44401.69 
wsv397 171 516 20296.002 
wsv398 127 384 13640.11 
wsv399 183 552 21549.802 
wsv403 641 1926 74059.497 
wsv405 184 555 20422.457 
wsv406 259 780 29827.044 
wsv407 227 684 25474.782 
wsv412 159 480 18741.44 
wsv414 121 366 13243.358 
wsv415 544 1635 61731.866 
wsv416 142 429 15289.804 
wsv418 228 687 25588.046 
wsv419 193 582 22543.364 
wsv421 204 615 22126.036 
wsv423 730 2193 81625.3 
wsv427 623 1872 70249.1 
wsv432 102 309 11486 
wsv433 1261 3786 141935.1 
wsv434 142 429 15719.2 
wsv440 607 1824 67194 
wsv442 800 2403 89430.9 
wsv446 526 1581 59341.3 
wsv447 1936 5811 215608.4 
wsv455 173 522 19374.7 
wsv457 265 798 30056.83 
wsv459 131 396 13429.807 
wsv461 157 474 18299.307 
wsv462 83 252 9777.375 
wsv464 288 867 32549.516 
wsv465 1243 3732 137990.225 
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wsv477 208 627 24218.888 
wsv479 509 1530 58184.225 
wsv482 179 540 19102.426 
wsv483 124 375 15041.476 
wsv484 216 651 24730.746 
wsv486 779 2340 90896.285 
wsv489 245 738 28078.405 
wsv492 136 411 16022.287 
wsv493 228 687 26236.694 
wsv495 86 261 10368.178 
wsv497 565 1698 64571.54 
wsv500 209 630 24683.229 
wsv502 1009 3030 113406.086 
wsv508 538 1617 61467.308 
wsv513 161 486 18178.875 
wsv514 2195 6588 244311.157 
wsv518 150 453 16757.91 
wsv524 68 207 7837.002 
wsv525 71 216 7773.331 




























2.3.2 Construction of WSSV Entry Clones 
 
The BP recombination reactions were completed to construct the entry clones. 
Except wsv026, wsv128, wsv178 and wsv179, entry clones of all the ORFs were 
constructed. The entry clones were screened by PCR and sequenced to confirm the 















































































































































































































































































































































































































































































































































































































































































































































































































































2.3.3 Construction of WSSV Expression Clones 
After sequence confirmation of the entry clones, LR recombination reactions were 
done to construct WSSV expression clones. Except 14 ORFs (wsv063, wsv091, wsv100, 
wsv139, wsv166, wsv192, wsv209, wsv277, wsv313, wsv332, wsv465 wsv387, wsv433 
and wsv497), all of the WSSV ORFs with entry clones were constructed expression 



















































2.4 Discussion and Conclusion 
With Gateway cloning system, the WSSV entry clones and expression clones 
were constructed in a high-throughput format efficiently. The entry clones can be easily 
transferred to different expression systems for functional analysis and protein expression. 
In this study, expression clones for E. coli expression system were constructed, 
considering the rapid cell growth and high expression level of the E. coli expression 
system. Some expression clones for baculovirus expression system were also constructed 
and may be used in future study. 
The vectors used for Gateway E. coli expression system are modified pET vectors 
containing N-terminal avi-tag and C-terminal 6x His tag or N-terminal 6x His tag and C-
terminal avi-tag. With 6x His-tag, the expressed recombinant WSSV proteins can be 
easily purified by Ni-NTA technology. Avi-tag is a 15-amino acid tag that can be 
specifically biotinylated by E. coli biotin ligase in vivo (Ashraf et al., 2004; Beckett, 
Kovaleva, and Schatz, 1999; Schatz, 1993). Site-specific biotinylated recombinant 
proteins could be generated with this biotinylation tag (de Boer et al., 2003; Tirat et al., 
2006). It was well known that biotin-avidin/streptavidin interaction is very stable and the 
strongest non covalent interaction (Werven and Timmers, 2006). It was shown that the 
biotinylated avi-tag is a versatile tool that can be used for protein detection, purification, 
immobilization, and co-immunoprecipitation studies (Pos, Bott, and Dimroth, 1994; 
Qureshi and Wong, 2002; Tucker and Grisshammer, 1996). In this study, the biotinylated 



































3.1 Introduction  
There are several factors including the expression system, expression vector, host 
strain and expression conditions that would affect the recombinant protein expression 
level. The recombinant WSSV proteins were first expressed in bacterial expression 
system. PET32a-AH and pET32a-HA were used as the expression vectors. Several host 
strains were used for the expression of recombinant WSSV proteins: BL21 Star (DE3) 
(Invitrogen), Origami B (DE3) (Novagen), Rosetta-gami B (DE3) (Novagen) and C41 
(DE3) (Lucigen). BL21 Star (DE3) is the first choice for recombinant WSSV protein 
expression as it can stabilize mRNA and is suitable for high-level recombinant protein 
expression. Origami host strain is the second choice as it promotes formation of disulfide 
bonds. The third choice for recombinant WSSV protein expression is Rosetta host strain, 
which facilitates expression with rare codons in bacterial cytoplasm. For the expression 
of membrane proteins, C41 host strain is a good choice as it allows the overexpression of 
membrane proteins (Miroux and Walker, 1996).   
3.2 Material and Methods 
 
3.2.1 Protein Analytical Techniques 
 
3.2.1.1 SDS-PAGE Gel Electrophoresis 
SDS-PAGE gel electrophoresis is a most often used protein analysis method. 
Proteins were separated according to their molecular weights. The electrophoresis 
apparatus used in SDS-PAGE gel electrophoresis was the Mini-Protean II Electrophoresis 
Cell (BioRad). The apparatus was assembled according to the manufacturer’s instruction 
manual. The stacking gel (2.5 %) was prepared by mixing 2 ml stacking gel buffer (0.5M 
Tris, pH 6.8), 1.3 ml 30 % acrylamide/bis-acrylamide, 80 µl 10 % SDS, 80 µl 10 % APS, 
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8 µl TEMED and 4.5 ml H2O. The separating gels were prepared according as following.  
 
Gel concentration 7 % 10 % 12 % 15 % 17.5 % 
buffer (1.5M Tris, pH 8.8) 1.9 ml 1.9 ml 1.9 ml 1.9 ml 1.9 ml 
30 % Acrylamide/bis-acrylamide (29:1) 3.5 ml 5 ml 6 ml 7.5 ml 8.75 ml 
10 % (w/v) SDS 150 µl  150 µl 150 µl 150 µl 150 µl 
10 % (w/v) APS 150 µl 150 µl 150 µl 120 µl 100 µl 
TEMED 10 µl 10 µl 10 µl 10 µl 8 µl 
H2O 9.21 ml 7.71 ml 6.71 ml 5.24 ml 4.01 ml 
Total volume 15 ml 15 ml 15 ml 15 ml 15 ml 
 
Before loading, protein samples were mixed with 5 × loading buffer (100 mM 
Tris pH 6.8, 200 mM dithiothreitol, 4 % SDS, 0.2 % bromophenol blue, 20 % Glycerol) 
and boiled for 5 ~ 10 mins to reduce the disulfide bonds. The gel was run at voltage of 70 
V 10 mins first, and then run at 200 V 35 mins, until the bromophenol blue reached the 
bottom of the gel. After SDS-PAGE, the gel was stained in Coomassie staining buffer (45 
% methanol, 15 % acetic acid and 0.1 % coomassie brilliant blue R-250) for 2 ~4 hours 
and then destained with the destain buffer containing 15 % methanol and 10 % acetic 
acid.  
 
3.2.1.2 Western Blot Analysis 
Firstly, proteins separated by SDS-PAGE gel electrophoresis were transferred to a 
nitrocellular membrane with Mini Trans-Blot Cell (Bio-rad). The transfer buffer used in 
this study was Towbin buffer (3.03 g/l Tris, 14.4 g/l Glycine, 20 % v/v Methanol). The 
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transfer was performed either at 70V for 3 h or at 30V overnight at 4°C. When the 
transfer was completed, the membrane was removed and then incubated with 5 % non-fat 
milk in TBST buffer (20 mM Tris, 150 mM NaCl, 0.05 % v/v Tween-20, pH 7.4) to 
block for 1 h at room temperature. After blocking, the membrane was briefly washed 
with TBST buffer. Then the membrane was incubated in the primary antibody diluted 
with TBST for 1 h at room temperature. The membrane was washed three times with 
TBST buffer. After washing, the membrane was incubated in the horseradish peroxidase 
(HRP) conjugated secondary antibody diluted with TBST buffer (usually 1:5000 
dilutions). To remove the unbound secondary antibody, the membrane was washed with 
TBST extensively. The chemiluminescence produced by the HRP conjugated secondary 
antibody was detected with the SuperSignal West Pico System (Pierce). 
3.2.1.3 MALDI TOF Spectrometry to Identify Proteins 
 
The target protein bands were individually excised from the destained gels and 
subsequently minced into 1 mm3 particles with a scalpel. Each gel band was treated with 
100 µL of 50 mM NH4HCO3 in 50 % CH3CN twice. The gel bands were dehydrated with 
50 µL CH3CN and then dried in a vacuum centrifuge for 30 mins twice. The gel bands 
were reswelled in 20 µL of solution containing 10 mM dithiothreitol /100 mM NH4HCO3 
and incubated at 56 °C for 1 h. This solution was subsequently replaced with 20 µL 
solution containing 55 mM iodoacetamide/100 mM NH4HCO3 and incubated in the dark 
at room temperature for 1 h with occasional vortexing. The liquid solution was aspirated 
and the gel particles were then washed with 100 µL of 100 mM NH4HCO3 solution for 
10 mins. The solution was aspirated again and the gel particles were dehydrated in 100 
µL CH3CN for 10 mins. The wash and dehydration steps were repeated twice. The final 
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solution was removed and the gel particles were dried in a vacuum centrifuge. The gel 
bands were digested with appropriate volume of 12.5 ng/µL trypsin (sequencing grade 
modified, Promega) in 50 mM NH4HCO3 and incubated at 4 °C for 30 mins. The 
redundant trypsin solution was discarded and the gel bands were incubated at 37 °C 
overnight. The liquid solution was aspirated and the gel particles were then treated with 
20 mM NH4HCO3 and 5 % formic acid in 50 % CH3CN twice respectively. All the 
supernatants were combined and dried in a vacuum centrifuge for the purpose of 
extracting the peptides. 
The dried peptides were dissolved in 3 to 20 µL 50 % CH3CN containing 0.1 % 
TFA. The 0.5 µL dissolved peptides were spotted onto a target plate, followed by an 
equal volume of 10 mg/mL α-cyano-4-hydroxycinnamic acid (CHCA) in 50 % CH3CN 
containing 0.1 % TFA. After the samples were dried under ambient conditions, the 
MALDI sample plate was loaded into a Voyager-DE STR BioSpectrometry Workstation 
mass spectrometer (Applied Biosystems). Mass spectra was acquired with 20.5 kV, 73.5 
% of grid, and a delayed time of 380 ns under a positive-ion reflector mode. Final 
identification of a protein was an integrated decision from hits, MOWSE scores, protein 
coverage and ranks at each protein band (Song et al., 2006). 
3.2.2 Expression of Recombinant WSSV Proteins  
3.2.2.1 Transformation of BL21 Cells  
To express the recombinant WSSV proteins, the expression clones containing 
WSSV ORFs were transformed to BL21 cells. One microliter of WSSV expression clone 
and 1 µl biotin ligase vector (enables the recombinant protein to be biotinylated) were 
added into the tube containing 100 µl BL21 Star (DE3) competent cells and mix gently.  
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After incubation on ice for 30 mins, the mixture was heat-shocked at 42 °C for 1 min and 
immediately chilled on ice for 2 min. Eight hundred microliters of fresh LB medium was 
added to the tube containing transformed cells and the tube was incubated at 37 °C with 
shaking for 45 min. The cells were spread onto LB agar plates (containing 100 µg/ml 
ampicillin and 50 µg/ml chloramphenicol). The plates were incubated at 37 °C overnight.  
3.2.2.2 Expression and Solubility Test of Recombinant WSSV Proteins 
 
A colony was picked from the plate and inoculated with LB medium (containing 
the same antibiotics with same concentration of the LB plates) and shaken at 37 °C 
overnight. Part of the overnight culture was mixed well with glycerol (0.5 ml overnight 
culture with 0.5 ml 50 % glycerol in LB medium) and kept at -80 °C as stock. Part of the 
overnight culture was inoculated into 4 ml new LB medium at the ratio of 1:100. When 
the bacterial cells were grown to a concentration of approximately OD 600 = 0.5 ~ 0.8 at 
37 °C, IPTG was added to induce expression of the fusion proteins with a final 
concentration of 0.5 mM. Biotin solution was also added to the culture to facilate the 
protein biotinylation. Then the bacterial cells were kept shaking overnight at 18 °C if not 
specified. One ml of the uninduced bacteria cells was kept shaking together as control. 
The proteins were extracted using B-PER® Bacterial Protein Extraction Reagent (Pierce). 
Five hundred microliters of the induced bacterial cells were centrifuged at 9000 × g for 5 
mins in a microcentrifuge.  The induced cells were resuspended in 100 µl of B-PER® 
Reagent by either vigorously vortexing the mixture for 1 min or by pipetting up and 
down until the cell suspension is homogeneous. The induced cells were centrifuged at 
15,000 × g for 10 mins at 4 °C to separate the soluble proteins from the insoluble proteins. 
The supernatant was collected as soluble sample and the pellet was resuspended with 100 
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µl of B-PER® Reagent as insoluble sample. Another 0.5 ml of the induced bacterial cells 
and 0.5 ml uninduced bacterial cells were centrifuged at 9000 × g for 5 mins separately. 
The pellet was resuspended in 100 µl of B-PER® Reagent as induced sample and 
uninduced sample separately. The uninduced, induced, soluble and insoluble samples 
were run for SDS-PAGE and followed with Western Blot assay to determine the 
solubility of the recombinant WSSV proteins. Since the recombinant WSSV proteins 
were biotinylated in vivo in the process of expression, streptavidin conjugated with HRP 
was used to detect the protein expression level and solubility in the Western Blot assay.  
3.2.3 Large Scale Culture and Purification of Recombinant WSSV Proteins 
After identifying the expression level and solubility of the recombinant WSSV 
proteins by Western Blot assay, the recombinant proteins expressed as soluble proteins in 
the bacterial cytoplasm and the recombinant proteins expressed in bacterial cytoplasmic 
inclusion bodies containing few cysteine residues were chosen for large scale culture and 
purification. The culture procedure was same as above, with the culture volume increased 
to 1 L.  
The soluble recombinant WSSV proteins were purified under native condition. 
The cultured bacterial cells were collected by centrifugation and resuspended in native 
lysis buffer (100 mM Tris, 500 mM NaCl, 10 mM Imidazole, pH 8.0). After treatment 
with chicken egg lysozyme (final concentration of 1 mg/ml) for 30 mins, the cell 
suspension was sonicated and centrifuged at 27,200 × g for 20 minutes (Beckman J2-21).  
The supernatant was mixed with the Ni-NTA beads and incubated at 4 °C for 2 h. The 
bound mixture of beads and cell lysate was added to a clean column and washed 
adequately with native wash buffer (100 mM Tris, 500 mM NaCl; 20 mM Imidazole, pH 
 58
8.0). The bound proteins were eluted with 5 ml native elution buffer (100 mM Tris, 500 
mM NaCl, 250 mM Imidazole, pH 8.0) for 4 times. The purity of the proteins was 
examined by 10-15 % SDS-PAGE and the corresponding bands of the recombinant 
WSSV proteins were sent for MALDI-TOF mass spectrometry analysis.  
The insoluble recombinant WSSV proteins were purified under denaturing 
condition. The cultured cells were collected by centrifugation and resuspended in 
denature lysis buffer A (0.1 M NaH2PO4, 10 mM Tris, 6M Guandine-HCL, pH 8.0). The 
cells were stirred at room temperature for 1 h. After that, the cell homogenate was 
centrifuged at 17,400 × g (Beckman J2-21) for 20 mins at room temperature.  The 
supernatant was mixed with the Ni-NTA beads and incubated at room temperature for 2 h. 
The bound mixture of beads and cell lysate was added to a clean column and washed 
adequately with denaturing wash buffer B (0.1 M NaH2PO4, 10 mM Tris, 10 mM 
Imidazole, 8 M Urea, pH 8.0). The bound proteins were eluted with 5 ml of denaturing 
elution buffer C  (0.1 M NaH2PO4, 10 mM Tris, 250 mM Imidazole, 8 M Urea, pH 6.3) 
for 4 times. The purity of the proteins was also examined by 15 % SDS-PAGE and the 
corresponding bands of the recombinant WSSV proteins were sent for MALDI-TOF 
mass spectrometry analysis.  
3.2.4 Desalting and Lyophilization of the Purified Proteins 
After the protein purity was examined by SDS-PAGE, the next step was to 
remove the salt in the eluted protein fractions. The desalting device used in this study was 
mainly Bio-Rad chromatography column packed with Sephadex G-25. Firstly, the 
desalting buffer (20 mM ammonium bicarbonate) above the gel surface was removed and 
the eluted protein sample was carefully layered on the surface of the gel. After the protein 
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sample flowed through the gel, the desalting buffer was added to the column with a 
peristaltic pump connected with the buffer reservoir. The desalted protein fractions were 
freezed at -80 °C overnight and then sent for lyophilization.  
 
3.3 Results and Discussion 
 
3.3.1 The Recombinant WSSV protein Expression in E. coli System  
 
The recombinant WSSV proteins were expressed in E. coli system with different host 
strains, culture temperature and isopropyl-β-D-thiogalactopyranoside (IPTG) concentration. 
The recombinant WSSV protein expression was started with Star-DE3 as host strain and the 
culture conditions were an overnight culture at 18 °C with 0.5 mM IPTG induction. If the 
recombinant WSSV proteins were not expressed or expressed as insoluble proteins under such 
conditions, the culture conditions would be changed or the host strains would be changed to 
Origami, Rossetta and C41. An example of recombinant WSSV protein expression identified 
by Western Blot assay was shown in Fig 3.1. Totally, 65 WSSV proteins were expressed as 




Fig 3.1 Representatives of recombinant WSSV protein expression  
 
M: molecular weight marker; UN: uninduced recombinant WSSV protein sample; In: 
induced recombinant WSSV protein sample; S: soluble recombinant WSSV protein 
sample; IS: insoluble recombinant WSSV protein sample. Streptavidin conjugated HRP 
was used to detect the protein expression level as the recombinant WSSV proteins were 
biotinylated by E. coli biotin ligase in vivo. Wsv421 was identified as soluble protein and 










3.3.2 Large Scale Cultured and Purified Recombinant WSSV Proteins 
 
After checking expression level of the recombinant WSSV proteins, the 
recombinant proteins expressed as soluble proteins and the recombinant proteins 
expressed as insoluble proteins containing few cysteine residues were chosen for large 
scale culture and purification. Several recombinant WSSV proteins were produced with 
high yield and purity.  But many of the recombinant WSSV proteins were poorly 
produced. Totally 33 purified proteins were obtained and 20 of them were purified as 
soluble proteins until now (Table 3.1). The purified recombinant WSSV proteins were 
run for SDS-PAGE analysis. An example of the purification of recombinant wsv069 is 
shown in Fig 3.2. The bands on the SDS-PAGE gel corresponding to the recombinant 
proteins were sent for MALDI-TOF mass spectrometry analysis. All of the purified 
proteins were confirmed by MALDI-TOF mass spectrometry analysis except wsv146, 
wsv321 and wsv386. The failure of MALDI-TOF mass spectrometry analysis may be due 
to the low molecular weight of these three proteins and less trypsin cleaving residues of 
lysine and arginine. An example of MALDI-TOF mass spectrometry result of 









Table 3.1 Summary of purified recombinant WSSV proteins 
Name MW (Da) Solubility MALDI 
wsv006 32748.61 Soluble OK 
wsv009 11044.93 Soluble OK 
wsv056 25664.97 Insoluble Ok 
wsv069 25014.01 Soluble OK 
wsv077 33122.6 Soluble OK 
wsv083 66440.65 Insoluble OK 
wsv134 24992.65 Soluble OK 
wsv188 47560.75 Insoluble OK 
wsv230 9205.516 Soluble OK 
wsv242 34370.315 Insoluble OK 
wsv254 31539.764 Insoluble OK 
wsv291 9289.458 Soluble Ok 
wsv302 21230.592 Soluble OK 
wsv306 47440.548 Insoluble OK 
wsv338 48187.088 Insoluble OK 
wsv407 25474.782 Soluble OK 
wsv421 22126.036 Soluble OK 
wsv432 11486 Insoluble OK 
wsv446 59341.3 Insoluble OK 
wsv477 24218.888 Soluble OK 
wsv489 28078.405 Insoluble Ok 
wsv493 26236.694 Soluble OK 
wsv500 24683.229 Soluble OK 
wsv076 31532.179 Insoluble OK 
wsv146 7080.554 Soluble Fail 
wsv321 13123.898 Soluble Fail 
wsv386 6760.598 Soluble Fail 
wsv492 16022.287 Soluble OK 
wsv010 11116.5 Soluble OK 
wsv340 29825.709 Insoluble OK 
wsv002 23146.24 Soluble OK 
wsv256 43138.192 Insoluble OK 













Fig 3.2 Purification of wsv069 by Ni-NTA resin 
Lane 1, molecular weight marker;  
Lane 2, induced recombinant wsv069 
Lane 3, flowthrough fraction in wsv069 purification  
Lane 4, wash fraction in wsv069 purification 



















Fig 3.3 MALDI-TOF MS result of wsv069 
MALDI-TOF MS confirmed that the identity of wsv069 with 34% coverage of 






































4.1 Introduction  
With the expressed and purified recombinant WSSV proteins in Chapter 3, 
protein array platform was applied to screen the interactions of WSSV proteins with host 
proteins. Common protein-protein interaction methods such as pull down assay, protein 
overlay assay and co-immunoprecipitation were used to validate the protein array results. 
4.2 Material and Methods 
4.2.1 Protein Array 
4.2.1.1 Labeling Probe Protein Samples with Dye 
Protein mixtures or single protein were used as protein array probe protein 
samples. The protein mixtures used were cytoskeleton and nuclear proteins from gill of 
healthy tiger shrimp. The shrimp cytoskeleton and nuclear proteins were extracted 
according to the compartmental protein extraction kit (Chemicon). The single protein 
used was actin (Sigma). The probe protein samples were incubated with Cy5 dye (Arrayit) 
for 2 h at room temperature (kept from light). Then the labeled fluorescent probe proteins 
were purified from the unincorporated dye by gel filtration. The labeled fluorescent probe 
proteins were stored at –80 °C until use. 
4.2.1.2 Protein Array Procedure 
 
The purified recombinant WSSV protein samples were dissolved in PBS buffer 
on ice. The protein samples were centrifuged at 1000 × g for 10 min at 4 °C and the 
supernatant were collected. Protein concentrations were measured and the final 
concentration of each protein was between 0.2-2.0 µg/µl. The protein samples were 
mixed 1:1 with 2X Protein Printing Buffer (ArrayIt) and stored in aliquot at –80 °C until 
use. The protein samples were printed onto strepavidin coated slides (Arrayit) 0.2 ul per 
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spot (3 repeats). After binding for 0.5 h in a humidity box, the slide printed with 
recombinant WSSV proteins was incubated in the SuperStrept avidin Blocking Buffer 
(ArrayIt) for 1 h at room temperature. The slide was washed with PBST buffer (PBS 
buffer supplemented with 0.1 % Tween-20) three times at room temperature. The 
fluorescent labeled protein sample was added to the slide and incubated for 2 h at room 
temperature in the humidity box and kept from light. The slide was washed with PBST 
for 3 times and pure water twice, followed drying the slide under nitrogen gas. Lastly the 
slide was scanned with the microarray scanner (Typhoon 9410) to get a fluorescent image.  
4.2.2 Pull Down Assay 
Cytoskeleton and nuclear proteins from gill of healthy tiger shrimp were used as 
prey proteins for pull down assay in this Chapter. As the recombinant WSSV proteins 
were biotinylated, so the Pull-down assays were performed according to the protocol of 
Profound Pull-Down Biotinylated Protein: Protein Interaction Kit (Pierce Biotechnology). 
Briefly, excessive recombinant WSSV protein was immobilized on streptavidin agarose 
beads in a column. After rotation for 1 h at 4 °C and biotin blocking step, the prey 
proteins were added and rotated overnight at 4 °C. The eluted protein fractions were 
analyzed by electrophoresis on a 12-15 % SDS-PAGE gel and stained with silver nitrate. 
Specific bands on the silver-stained gel were excised and sent for identification by mass 
spectrometry (Huynh et al., 2004). 
4.2.3 Protein Overlay Assay 
 
The specific protein samples were run on a 12-15 % SDS-PAGE gel and 
transferred onto NC membrane. The membrane was washed with TBST buffer briefly. 
Then the membrane was blocked with 5 % non-fat milk in TBST buffer for 1 h at room 
temperature. After blocking, the membrane was washed with TBST buffer. Then the 
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membrane was incubated with the primary probe for 1-2 h at room temperature. After 
binding, the membrane was washed three times with TBST buffer. The membrane was 
then incubated with the secondary probe conjugated with HRP for 1 h at room 
temperature. Lastly, the membrane was washed with TBST buffer extensively. The 
chemiluminescence produced by the HRP was detected with the SuperSignal West 
Pico System (Pierce). 
4.2.4 Co-immunoprecipitation 
 
The cell lysate sample was from epithelial tissue of infected crayfish. Firstly, the 
epithelial tissue of infected crayfish was homogenized in liquid nitrogen and then 
dissolved in lysis buffer [50 mM Tris-HCl pH 8.0, 150 mM NaCl, 1 % NP-40 and 1 × 
protease inhibitor cocktail (Roche)]. After centrifugation at 10,000 g for 15 mins at 4 °C, 
the supernatant was collected and stored at −80 °C until use. Fifty microliters of protein 
A agarose beads (Roche) was precleared with the lysis buffer and centrifuged at 10000 g 
for 30 seconds to remove the lysis buffer. One milliliter of the cell lysate was added to 
the tube containing 50 µl precleared beads and incubated with rotation at 4 °C for 1 h. 
The tube was centrifuged at 10000 g for 10 mins at 4 °C and the supernatant was 
transferred to a fresh tube. Antibody against the specific prey protein (5-10 µg) was 
added to the tube and incubated at 4 °C or room temperature for 1 h. Another 50 µl 
precleared beads was added in and incubated 1 h at 4 °C or room temperature. The tube 
was centrifuged at 10000 g for 30 seconds and the supernatant was carefully removed 
completely. The beads were washed 3-5 times with the lysis buffer. After the last wash, 
the supernatant was removed and 50 µl 2X SDS dye was added to the beads pellet. The 
tube was vortexed and heated at 90-100 °C for 5-10 mins. The tube was centrifuged at 
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10000 g for 5 mins and the supernatant was collected. The supernatant was analyzed by 
electrophoresis with a 12-15 % SDS-PAGE gel and transferred to a NC membrane for 
Western Blot analysis with specific antibodies. 
4.3 Results and Discussion 
4.3.1 Interaction of WSSV Proteins with Actin 
Actin was found to be co-purified in the process of purifying WSSV  and it was 
speculated that actin may play a role in WSSV morphogenesis (Tsai et al., 2004). A 
major WSSV structural protein VP26 (wsv311) was reported to have interaction with 
actin (Xie and Yang, 2005). Here we used protein array technology to study the potential 
interactions of WSSV proteins with actin.  Totally 21 recombinant WSSV proteins were 
spotted onto the streptavidin coated slide to interact with the probe of Cy5-labeled actin. 
It was found that wsv006, wsv254, wsv077, wsv407, wsv477 and wsv076 showed 
binding signal with different intensity (Fig 4.1). Among them, wsv254 showed the most 






























































Fig 4.1 Protein array of the WSSV proteins with actin 
 
The protein array contains 21 recombinant WSSV proteins spotted in triplicate on a 













To further confirm the protein array results, wsv006, wsv254, wsv407 and 
wsv477 were used as probes to interact with actin by protein overlay assay. Actin was run 
on a 10 lanes SDS-PAGE gel (1 µg per lane) and transferred to a NC membrane firstly. 
The NC membrane was cut into 10 strips (one lane per strip). The strips were probed with 
anti-actin antibody from rabbit and different recombinant WSSV proteins respectively, 
followed with probing of HRP conjugated anti rabbit IgG or HRP conjugated streptavidin. 
The result showed that wsv006 interacted with actin by this method (Fig 4.2). The reason 
why other WSSV proteins did not interact with actin by protein overlay assay may be that 
some proteins lose the interacting ability under the denature conditions of protein overlay 



































Fig 4.2. Protein overlay assay of WSSV proteins with actin 
 
Primary probes: 1. anti-actin antibody from rabbit; 3. actin; 4. wsv407; 5. TBST buffer; 6. 
wsv254; 7. wsv006; 8. wsv291; 9. wsv477;  10. wsv493. Secondary probes: 1.anti rabbit 
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Wsv254 showed the highest interacting signal with actin in the protein array result. 
Another effort to validate this protein array result by co-immunoprecipitation showed that 
wsv254 interacted with actin (Fig 4.3). Wsv254 was only recognized in the sample of 
wsv254 with anti-actin antibody and infected epithelial tissue. Purified recombinant 
wsv254 was added in the samples due to the low abundance of wsv254 in the infected 
epithelial sample. 
After entering the cell, the genome of most viruses must be transported either to 
the nucleus or to specific cytosolic membranes. Viruses often exploit the cytoskeleton 
and cellular motor proteins to move inside the cells (Alicia and Helenius., 2004). In 
recent years, an increasing amount of evidence describes various strategies used by 
viruses to use actin microfilaments to take control of the cellular cytoskeleton (Cudmore, 
Reckmann, and Way, 1997). Baculovirus was reported to utilize actin microfilaments for 
viral nucleocapsid transport from the site of virus entry to the nucleus (van Loo et al., 
2001). Same strategy is used by human immunodeficiency virus type 1 (HIV-1) (Liu et 
al., 1999). Vaccinia virus and simian virus (SV40) promote actin polymerization and use 
these functional micro-filaments to facilitate their intracellular movements, assembly, or 
budding (Ploubidou and Way, 2001). Wsv006 was identified as a WSSV structural 
protein in our proteomics study for the first time (Chapter 5 Table 5.3) and wsv254 is a 
known structural protein (VP281) (Huang et al., 2002a). By interacting with actin, both 
of the structural proteins may help the viral nucleocapsid to move toward the nucleus.  
Further study is required to find out the mechanism of the interaction and this may help to 











Fig 4.3 Co-immunoprecipitation of wsv254 with actin 
 
1. wsv254 with infected epithelial tissue only; 2. wsv254 with anti-actin antibody and 
infected epithelial tissue; 3. wsv254 with preimmune antibody and infected epithelial 
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4.3.2 Interaction of WSSV Proteins with Shrimp Cytoskeleton and Nuclear Proteins 
 
For the purpose to screen potential virus-host protein-protein interactions, protein 
array of the WSSV proteins was further applied to interact with shrimp cytoskeleton and 
nuclear proteins.  Totally 33 recombinant WSSV proteins were spotted onto the 
streptavidin coated slide to interact with the probes of Cy5-labeled shrimp cytoskeleton 
and nuclear proteins respectively. For the protein array probed with shrimp cytoskeleton 
proteins, wsv254, wsv340, wsv407, wsv421, wsv338 and wsv010 showed binding signal 
with different intensity (Fig 4.4). For the protein array probed with shrimp nuclear 
proteins, wsv006, wsv254, wsv340, wsv477 and wsv010 showed binding signal with 





































































































Fig 4.4 Protein array of the WSSV proteins with shrimp cytoskeleton proteins 
 
 The protein array contains 33 recombinant WSSV proteins spotted in triplicate on a 
























































































Fig 4.5 Protein array of the WSSV proteins with shrimp nuclear proteins 
 
The protein array contains 33 recombinant WSSV proteins spotted in triplicate on a 










To validate the protein array results, wsv254 and wsv407 were chosen for pull 
down assay with shrimp cytoskeleton proteins as both proteins showed high interacting 
signal (Fig 4.4).  Wsv254 and wsv493 were chosen for pull down assay with shrimp 
nuclear proteins as wsv254 show a high interacting signal and wsv493 was reported to 
have nuclear localization signals and targeted nucleus (Chen et al., 2002) (Fig 4.5). But 
no specific binding protein has been successfully identified by MALDI mass 
spectrometry. It is obvious that the complexity of the shrimp cytoskeleton and nuclear 
proteins makes it difficult to identify a specific protein binding with the virus proteins. 
The interaction conditions for pull down assay will be optimized and other protein-
protein interaction methods will be applied to validate the protein array results.  
In conclusion, protein array technology is a powerful tool to screen novel protein-
protein interactions in a high throughput format (Smith et al., 2005).  The protein array of 
the WSSV proteins probed with actin identified potential interactions of the WSSV 
proteins with actin. From the protein array results probed with shrimp cytoskeleton and 
nuclear proteins, several WSSV proteins were also found to interact with shrimp 
cytoskeleton and nuclear proteins separately. But same as other high throughput 
screening technologies, protein array may produce false positive or false negative results, 
so it is necessary and more convincing to validate the protein array data by other 
conventional methods which are used to study protein-protein interactions. Two of the 
interactions of WSSV proteins with actin were confirmed by protein overlay assay and 
co-immmunoprecipitation. More protein-protein interactions will be screened with 
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5.1 Introduction  
 
Viral structural proteins play critical roles in viral structure, assembly, infection, 
cell adhesion, signal transduction and evasion of the host’s antiviral defenses.  Among 
the viral structural proteins, envelope proteins play vital roles, such as binding with 
receptors or penetrating into host cells by membrane fusion (Alicia and Helenius., 2004).  
In this chapter, shotgun proteomics and iTRAQ technology were applied to study the 
WSSV structural proteins. Localization and potential function of two novel structural 
proteins were studied by routine technologies. 
5.2 Material and Methods 
 
5.2.1 Proliferation and Isolation of WSSV Virions 
The virus used in this study was originated from WSSV-infected Penaeus 
chinensis (China isolate).  The genome accession number is AF332093. Haemolymph of 
infected red claw crayfish, Cherax quadricarinatus was used as virus inoculum (Wu et al., 
2002). The infected haemolymph was diluted 1:4 with PBS buffer and stored at -80 oC as 
the stock. Before injecting the experimental crayfish, the stock haemolymph was diluted 
10 times in PBS and centrifuged at 1,000 × g for 10 mins and then the supernatant was 
filtered with 0.45 µm filter. The healthy crayfishes were injected with 0.3-0.4 ml of the 
virus inoculum intramuscularly between the second and third abdominal segments.  
Haemolymph was collected from moribund crayfish during the period of 4 th to 6 th days 
after infection. After centrifugation at 2,000 × g for 10 mins, the supernatant was layered 
on the top of a 30 %, 40 %, 50 % and 60 % (w/v) stepwise sucrose gradients and 
ultracentrifuged at 53,000 × g (Beckman XL-90, Rotor SW28) for 1 h at 4 °C.  The virus 
bands were collected and mixed with TN buffer (20 mM Tris-HCl and 400 mM NaCl, pH 
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7.4) and repelleted at 53,000 × g for 1 h at 4 °C. The white pellet was rinsed with TN 
buffer and centrifuged at 12,000 × g for 0.5 h at 4 °C three times, and then resuspended in 
TN buffer. The purified virus samples were subjected to negative staining with 2 % 
phosphotungstic acid and were examined under the transmission electron microscope 
JEOL JEM 2010F.  
5.2.2 Shotgun Proteomics Analysis of WSSV Structural Proteins 
After obtaining sufficient purified viral protein, in-solution digestion and LC 
separation of tryptic peptides were carried out following the procedures as described 
previously (Song et al., 2006).  The proteins extracted from purified WSSV virions were 
mixed with 50 mM Tris-HCl (0.1 % SDS, pH 8.5) at 1:5 rates.  Then the extracted 
proteins were reduced with triscarboxyethylphosphine and alkylated with iodoacetamide. 
After that, the proteins were digested with sequencing-grade porcine trypsin (Promega, 
Madison, WI).  The peptide mixture was then separated using an Ultimate LC system 
(Dionex-LC Packings, Sunnyvale, CA) equipped with a Probot MALDI spotting device.  
Around 10 µg of peptide mixture was captured by a 0.3 × 1-mm trap column (3-µm C18 
PepMap, 100 Å, Dionex-LC Packings) and separated by a 0.075 × 150-mm analytical 
column (3-µm C18 PepMap, 100 Å, Dionex-LC Packings) at a flow rate of 0.4 µL/min.  
The mobile A was 2 % ACN, 0.05 % TFA and B was 80 % ACN, 0.04 % TFA 
respectively.  The LC gradients were: 0-20 % B in 10 mins, then 20-60 % B over 3 hrs, 
and 60-100 % B in 1 min and kept at 100 % B for 5 mins.  The LC fractions were then 
mixed with MALDI matrix solution (7 mg/mL α-cyano-4-hydroxycinnamic acid and 130 
µg/mL ammonium citrate in 75 % ACN) before spotting onto MALDI target plates. 
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An ABI 4700 Proteomics Analyzer MALDI TOF/TOF mass spectrometer 
(Applied Biosystems, Foster City, CA) was used to analyze the samples.  The instrument 
was controlled by 4000 Series Explorer version 3.0.  For MS analyses, typically 1,000 
sub-spectra were accumulated.  Peaks were detected with the minimum signal to noise 
ratio (s/n) set to 15 and the peaks were de-isotoped.  MS/MS analyses were carried out 
using nitrogen at collision energy of 1 kV and a collision gas pressure of ~ 9.0 × 10-7 torr.  
Two thousand to ten thousand sub-spectra were combined for each spectrum using stop 
conditions based on the quality of the data.  The spectra were smoothed using Savitsky-
Golay method with points across peak (FWHM) set to 3 and polynomial order to 4.  The 
peaks were de-isotoped and only the peaks with s/n ≥ 10 were picked. 
GPS Explorer software version 3.0 (Applied Biosystems) was used to create and 
search files with the MASCOT search engine version 2.0 (Matrix Science, Boston, MA) 
to identify the viral proteins.  A database (64335 entries) including all predicted ORFs 
from three WSSV isolates (2013 entries) together with the International Protein Index 
human database version 3.16 (www. ebi.ac.uk/IPI/IPIhelp.html, 62322 entries) was used 
in order to minimize false positive identifications.  The search was restricted to tryptic 
peptides and one missing cleavage was acceptable.  Cysteine carbamidomethylation, N-
terminal acetylation, pyroglutamation (Glu or Gln), and methionine oxidation were 
selected as variable modifications.  Precursor error tolerance and MS/MS fragment error 
tolerance were set to 60 ppm and 0.4 Da respectively.  Only the top-ranked peptide 
matches were considered for protein identification.  For peptide matches with expect 
value more than 0.05, the MS/MS spectra were further validated manually. 
5.2.3 Separation of Viral Envelope and Nucleocapsid Proteins 
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A previously validated separation procedure was applied with modification (Tsai 
et al., 2006).  The purified virus was treated with the lysis buffer [20 mM Tris-HCl, 5 
mM EDTA-Na2, 1 % triton X-100, 0.5 M NaCl, pH 7.4 and 1 × protease inhibitor 
cocktail (Roche Diagnostics Asia Pacific Pte. Ltd)] for 30 mins at 4 °C.  Then the virus 
was divided into two equal volumes.  One half was set aside as the total viral proteins, 
while the other half was separated into two fractions, supernatant and pellet, by 
centrifugation at 200,000 × g for 1 h at 4 °C.  The pellet fraction was washed one more 
time with the lysis buffer and centrifuged again for 1 h.  The pellet was resuspended in an 
equal volume of the lysis buffer as the envelope fraction. 
5.2.4 Western Blot Analysis of Envelope and Nucleocapsid Fractions 
Virion-associated proteins from each fraction were resolved on 12 % SDS-PAGE 
gels and continued with Western blot analysis.  The transferred nitrocellular membrane 
was blocked with 5 % non-fat milk in 1 × TBST buffer (20 mM Tris base, 137 mM NaCl, 
0.1 % Tween 20, pH 7.6) at room temperature for 1 h and then subjected to Western blot.  
Primary antibodies were used with the following concentrations: anti-VP28 (wsv421) 
polyclonal antibody from rabbit (1:2,000), anti-VP24 (wsv002) and anti-VP466 (wsv308) 
polyclonal antibody (1:2,000) from mouse.  The anti-rabbit or anti-mouse horseradish 
peroxidase-conjugated antiserum was used as secondary antibodies and diluted 1:5,000 
(GE Healthcare, Uppsala, Sweden).  Pierce supersignal west pico chemiluminescent 
substrate (Pierce, Rockford, IL) was used according to the manufacturer’s protocol, and 
the protein bands were visualized by lumi-film chemiluminescent detection film (Roche). 
5.2.5 iTRAQ Labeling and Two Dimensional (2D) LC-MALDI MS to Determine 
Viral Protein Localization 
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Total viral proteins of one hundred microgram and the equivalent envelope and 
nucleocapsid protein fractions (separated from 100 µg total viral proteins) were processed 
using 2D Clean-Up kit (GE Healthcare) and re-suspended in the dissolution buffer (0.5 M 
triethylammonium bicarbonate, pH 8.5, containing 0.1 % SDS).  The samples were then 
reduced and blocked cysteines according to the protocol of the iTRAQ kit (Applied 
Biosystems).  Ten microgram trypsin (Applied Biosystems) were added and the samples 
were digested at 37 °C overnight.  The samples were then vacuum-dried and reconstituted 
with 30 µL dissolution buffer, and labeled with iTRAQ tags as follows:  total viral 
proteins with iTRAQ 114 reagent; the envelope fraction with iTRAQ 115 reagent; and 
the nucleocapsid fraction with iTRAQ 116 reagent.  The labeled samples were then 
pooled and purified using a strong cation exchange (SCX) column (Applied Biosystems) 
and the bound peptides were eluted with 5 % NH4OH in 30 % methanol. 
After drying, the iTRAQ-labeled peptides were resuspended with 20 µL 5 mM 
KH2PO4 buffer (5 % ACN, pH 3.0) and separated using an Ultimate dual-gradient LC 
system (Dionex-LC Packings).  The first dimension separation used a 0.3 × 150-mm SCX 
column (FUS-15-CP, Poros 10S, Dionex-LC Packings). The mobile phase A was 5 mM 
KH2PO4 buffer, pH 3, containing 5 % ACN and mobile phase B was 5 mM KH2PO4 
buffer, pH 3, containing 5 % ACN and 500 mM KCl with a flow rate of 6 L/min. The 　
elutes with step gradients of mobile phase B (unbound, 0-5, 5-10, 10-15, 15-20, 20-30, 
30-40, 40-50, and 50-100 %)  were captured alternatively with two 0.3 × 1 mm trap 
columns (3 µm C18 PepMap, 100 Å, Dionex-LC Packings) and washed with 0.05 % TFA 
to remove salts.  The second dimension separation was performed with a 0.2 × 50 mm 
reverse-phase column (Monolithic PS-DVB, Dionex-LC Packings), using mobile phase 
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A (2 % ACN with 0.05 % TFA) and mobile phase B (80 % ACN with 0.04 % TFA) 
respectively with a gradient of 0-60 % mobile phase B in 15 min and a flow rate of 2.7 
µL/min.  The LC fractions were mixed with MALDI matrix solution in a flow rate of 5.4 
µL/min through a 25 nL mixing tee (Upchurch Scientific, Oak Harbor, WA) and spotted 
to 192 well MALDI target plates (Applied Biosystems) with a Probot Micro Fraction 
collector (Dionex-LC Packings). 
MS analysis was performed and the MS/MS analysis settings were the same as 
the shotgun analysis except that a collision gas pressure was changed to ~ 2 × 10-6 Torr. 
Six thousand shots were combined for each spectrum for the precursor ions with s/n ≥ 
100.  Ten thousand shots were acquired for the precursors with s/n between 50 and 100.  
The peak processing and detection parameters were same of the shotgun analysis as 
described above.  GPS Explorer software (version 3.5; Applied Biosystems) employing 
MASCOT search engine (version 2.1; Matrix Science) was used for peptide and protein 
identifications and iTRAQ quantification.  The database used was the same one as 
mentioned above and restricted to tryptic peptides.  Cysteine methanethiolation, N-
terminal iTRAQ labeling and iTRAQ labeled lysine were chosen as fixed modifications 
and methionine oxidation as a variable modification.  One missing cleavage was 
acceptable. Precursor error tolerance and MS/MS fragment error tolerance were set to 
120 ppm and 0.4 Da respectively.  Maximum peptide rank was set to 1 and minimum ion 
score confidence interval for peptide was set to 0.  The MS/MS spectra were manually 
inspected for the proteins with low ion scores (≤ 30). 
5.2.6 Antibody Preparation of Novel WSSV Structural Proteins 
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Novel WSSV structural proteins wsv010 and wsv432 identified by shotgun 
proteomics with acceptable recombinant protein expression level were chosen to raise 
polyclonal antibody from rabbits. The expression and purification procedures were same 
as in Chapter 3. After determination of the protein concentrations, the purified 
recombinant WSSV proteins were separated by SDS-PAGE. The bands according to the 
recombinant WSSV protein were cut and sent to Bam Biotech Co., LTD (Xiamen, Fujian, 
P. R. China) for antibody production.  
5.2.7 Localization Study by Western Blot Analysis and Immunogold Electron 
Microscopy Technique 
The procedure of western blot is the same for envelope and nucleocapsid proteins 
as described above. The primary antibodies against wsv010 and wsv432 were diluted 
1:1,000 respectively.  
IEM technique was applied to verify the localization of wsv010 and wsv432 on 
virus particles.  The virus was treated with 0.1 % Tween 20 to partially separate the 
envelope fraction from the nucleocapsid fraction.  The treated virus and the nucleocapsid 
fraction separated by centrifugation were spotted onto carbon-coated nickel grids for 5 
mins.  The grids were blocked with 5 % BSA in 0.2 M phosphate buffer (pH 7.3) for 0.5 
h at room temperature.  Anti wsv010 and wsv432 antibodies were used as the primary 
antibody for 2 h incubation at room temperature.  Pre-immune rabbit serums were used as 
negative controls.  After washing with the phosphate buffer for 3 times, goat anti-rabbit 
Ig G conjugated with 15 nm gold beads (Electron Microscopy Sciences, Hatfield, PA) 
was used as the secondary antibody and incubated for 2 h at room temperature.  After 
sufficient washing with the buffer, the grids were stained with 2 % solution of 
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phosphotungstic acid and examined under the transmission electron microscope Philips 
CM 10. 
5.2.8 Protein-Protein Interaction Studies of Novel WSSV Structural Proteins 
Pull down assay and coimmunoprecipitation were applied to study interactions of 
wsv010 and wsv432 with virus and host proteins. The procedures were same as described 
in Chapter 4. 
 
5.3 Results  
 
5.3.1 Identification of Virion-associated Proteins by Shotgun Proteomics 
The purity of isolated WSSV virions was confirmed by electron microscopy (Fig 
5.1).  The structural proteome of WSSV was analyzed by shotgun proteomics employing 
offline LC-MALDI workflow.  Totally, 45 viral proteins were detected with amino acid 
sequences that matched WSSV ORFs (Table 5.1).  Although wsv419 only contained one 
top-ranked peptide with a MASCOT score of 28, the MS/MS spectrum was manually 
inspected and was considered as a reliable assignment.  One protein’s predicted ORF can 
only be found in the Taiwan isolate (WSSV349) and Thailand isolate (ORF144).  So we 
used WSSV349 to name it.  Although a comprehensive study on the WSSV proteome 
was carried out by the gel-based approach earlier, our shotgun method has successfully 











FIG 5.1 Electron micrographs of negatively stained WSSV 
 
             A, intact enveloped virions.   
























C.I. % hpi3 TM4 SP5 
RGD or 
KGD6 
Alternative Names &  
References 
1 wsv002 gi|17158106 23 8.6 12 1327 100 24 TM SP KGD VP24 (34) 
2 wsv006 gi|17158110 33 4.3 2 35 97.088 24 TM   this study 
3 wsv010 gi|17158114 11 4.4 1 48 99.871 12    this study 
4 wsv011 gi|17158115 144 5.5 10 586 100 2 TM   VP53A (11) 
5 wsv021 gi|17158125 23 9.4 1 74 100 24 TM   this study 
6 wsv035 gi|17158139 108 6.7 14 485 100 24 TM  RGD VP110 (11) 
7 wsv037 gi|17158141 144 5.2 5 120 100 24   KGD VP160B (23) 
8 wsv115 gi|17158219 108 6 10 563 100 24 TM   VP53B (11) 
9 wsv131 gi|17158235 53 4.9 2 135 100 24    this study 
10 wsv134 gi|17158238 25 6.2 4 93 100 2    this study 
11 wsv136 gi|17158240 15 8.9 2 80 100 24 TM   this study 
12 wsv143 gi|17158247 259 5.2 18 963 100 2   KGD this study 
13 wsv161 gi|17158265 85 5.6 3 111 100 2    this study 
14 wsv209 gi|17158313 174 6 20 627 100 24   R/KGD VP187 (40) 
15 wsv216 gi|17158320 132 5.8 22 930 100 24    VP124 (19) 
16 wsv220 gi|17158324 76 5.5 2 32 94.88 2 TM   VP674,VP73,VP76 (10,11,24) 
17 wsv230 gi|17158334 9 4.2 1 55 99.972 2    this study, VP9 (35) 
18 wsv237 gi|17158341 33 4.6 4 271 100 24    VP292, VP41A (10,11) 
19 wsv238 gi|17158342 51 4.8 6 321 100 12 TM SP KGD VP51A (11) 
20 wsv242 gi|17158346 34 5.7 8 419 100 24    VP300, VP41B (10,11) 
21 wsv254 gi|17158357 32 4.7 5 267 100 24   RGD VP281, VP36B (10,11,13) 
22 wsv256 gi|17158359 43 4.7 6 244 100 24 TM SP  VP384, VP51B (10,11) 
23 wsv259 gi|17158362 35 4.7 3 78 100 24    VP38A (11) 
24 wsv271 gi|17158374 134 7.5 9 287 100 24   RGD VP136A (11) 
25 wsv284 gi|17158387 11 4.9 1 39 98.89 2 TM SP  VP13A (11) 
26 wsv289 gi|17158391 175 6.4 21 851 100 2    VP160A (23) 
27 wsv306 gi|17158408 47 5.4 3 170 100 24    VP39A (11) 
28 wsv308 gi|17158410 52 6.5 7 458 100 12    VP466, VP51C (10,11) 
29 wsv311 gi|17158413 22 9.3 9 911 100 12 TM   VP26 (34) 
30 wsv321 gi|17158423 13 9.3 1 91 100 12 TM SP  VP13B (11) 
31 wsv324 gi|17158426 9 9.3 3 166 100 2    this study 
32 wsv325 gi|17158427 51 8.7 7 320 100 12 TM   VP60A (11) 
33 wsv338 gi|17158440 48 4.7 3 153 100 24 TM SP  VP11 (11) 
34 wsv339 gi|17158441 32 5 4 176 100 24    VP39B (11) 
35 wsv340 gi|17158442 30 6.6 2 84 100 24   RGD VP31(11) 
36 wsv360 gi|17158462 664 6.4 165 12145 100 24   R/KGD VP664 (11,33) 
37 wsv386 gi|17158488 7 8 1 111 100 24 TM SP  VP68, VP12B (10,11) 
38 wsv414 gi|17158516 13 4.4 3 328 100 12 TM   VP19 (42) 
39 wsv415 gi|17158517 62 7 11 506 100 12   KGD VP544, VP60B (10,11) 
40 wsv421 gi|17158523 22 4.7 10 1054 100 12 TM SP  VP28 (34) 
41 wsv432 gi|17158534 12 5.8 1 73 100 24   RGD this study 
42 wsv442 gi|17158543 89 6.2 12 715 100 24    VP800, VP95 (10,11) 
43 wssv349 gi|19481941 11 9.5 1 49 99.902 24 TM   this study 
44 wsv1987 gi|17158302 31 6.4 3 50 99.922 24       VP32 (11) 
45 wsv419 gi|17158521 23 9.2 1 28 86.871 NA       this study 
1 Based on the genome of the China isolate, except for wssv349 (Taiwan isolate). 2 Predicted molecular mass.  3 hpi, hours post infection that 
ORFs started expression.  NA, not available.  4 TM, transmembrane domain.  5 SP, signal peptide sequence.  6 potential cell-adhesion sequences.  7 
WSSV proteins with the best peptide ion scores ≤ 30 are listed at the bottom of the table and separated from other proteins with a dashed line. 
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5.3.2 Separation of WSSV Envelope and Nucleocapsid Proteins 
In this study, the tegument proteins could not be distinguished from envelope 
proteins, so we classified viral structural proteins as envelope proteins (including 
tegument proteins) and nucleocapsid proteins.  Western blot analysis with antibodies 
against VP28, VP24 and VP466 was carried out to check the separation of viral proteins 
(Fig 5.2). It was demonstrated that envelope proteins and nucleocapsid proteins were 





























FIG 5.2 Western blot analysis of total proteins, envelope and nucleocapsid proteins  
  
Three antibodies used were anti-VP466, VP28 and VP24, respectively.  The total protein 









5.3.3 Localization of Structural Proteins in WSSV by iTRAQ 
To localize various structural proteins in WSSV, a quantitative proteomics 
experiment was carried out using iTRAQ reagents and 2D LC-MALDI MS.  The 
procedure of this experiment was outlined in Fig 5.3.  After separation of the purified 
virus, total viral proteins, envelope proteins and nucleocapsid proteins were labeled with 
iTRAQ reagents 114, 115 and 116, respectively.  Because of their enrichment through the 
separation process, we expected that envelope proteins would have higher 115/114 ratios 
than 116/114 ratios, whereas nucleocapsid proteins would instead have lower 115/114 
ratios compared with 116/114 ratios.  Fig 5.4 showed the representative MS/MS spectra 
of iTRAQ ratios from an envelope protein wsv009 and a nucleocapsid protein wsv289 
determined in this study.  Based on the iTRAQ reporter ion ratios, we observed 23 
structural proteins as envelope proteins and 6 as nucleocapsid proteins (Table 5.2).  
Wsv198, wsv216, wsv230, wsv238, wsv242, wsv256 and wsv289 were the 7 proteins 
with best ion scores ≤ 30.  These proteins have been confidently identified as viral 
structural proteins by the shotgun proteomics study, and the peptides matched were all 
top-ranked in the iTRAQ study, so these protein assignments should be reliable.  With the 
iTRAQ approach, we have validated 11 envelope proteins and 4 nucleocapsid proteins 
that were previously identified.  Moreover, we have identified additional 12 envelope 
proteins and 2 nucleocapsid proteins, demonstrating the effectiveness of this approach in 
the study of virus subproteomes.  Five newly identified structural proteins by shotgun 
proteomics and 23 known proteins were verified in the iTRAQ study.  One envelope 
protein wsv295 was identified for the first time in our iTRAQ study. All known 






FIG 5.3 The iTRAQ labeling workflow and 2D LC MS for the localization of structural 
proteins in WSSV.   
 
The virus envelopes were separated from the nucleocapsids after detergent treatment.  To 
quantitatively distinguish envelope proteins from nucleocapsid proteins, total viral 
proteins, proteins from the envelope fraction and the nucleocapsid fraction were reduced, 
cysteine-blocked and digested with trypsin, respectively.  The tryptic peptides were 
labeled with 114, 115, and 116 iTRAQ reagents, respectively.  Then, the combined 
peptide mixture was cleaned up using SCX chromatography.  The eluate was further 
separated by 2D LC coupling SCX with reversed phase chromatography and the column 
effluent was added with MALDI matrix solution and spotted on MALDI target plates, 

















FIG 5.4  Representative iTRAQ reporter ion spectra of an envelope protein wsv009 and a 



























Ratio ± SD 
(115/114)1 
Avg iTRAQ 





1 wsv002 gi|17158106 7 452 100 0.741 ± 0.184 0.219 ± 0.193 E 
2 wsv006 gi|17158110 2 166 100 0.742 ± 0.006 0.075 ± 0.135 E 
3 wsv009 gi|17158113 2 126 100 0.722 ± 0.182 0.161 ± 0.093 E 
4 wsv011 gi|17158115 6 160 100 0.702 ± 0.245 0.280 ± 0.188 E 
5 wsv021 gi|17158125 2 69 99.999 0.674 ± 0.368 0.284 ± 0.071 E 
6 wsv115 gi|17158219 1 38 98.591 0.517 ± 0.049 0.420 ± 0.027 E 
7 wsv143 gi|17158247 4 202 100 0.446 ± 0.252 0.497 ± 0.203 NC 
8 wsv209 gi|17158313 4 230 100 0.635 ± 0.261 0.411 ± 0.299 E 
9 wsv254 gi|17158357 1 40 99.121 0.663 ± 0.123 0.322 ± 0.073 E 
10 wsv259 gi|17158362 2 82 100 0.656 ± 0.192 0.348 ± 0.230 E 
11 wsv271 gi|17158374 2 89 100 0.476 ± 0.099 0.582 ± 0.059 NC 
12 wsv295 gi|17158397 1 35 96.96 0.448 ± 0.033 0.379 ± 0.007 E 
13 wsv306 gi|17158408 1 50 99.905 0.933 ± 0.248 0.321 ± 0.051 E 
14 wsv308 gi|17158410 2 89 100 0.343 ± 0.131 0.517 ± 0.114 NC 
15 wsv311 gi|17158413 9 781 100 0.792 ± 0.259 0.194 ± 0.227 E 
16 wsv321 gi|17158423 1 46 99.79 0.703 ± 0 0.342 ± 0 E 
17 wsv325 gi|17158427 2 50 99.92 0.694 ± 0.149 0.208 ± 0.084 E 
18 wsv360 gi|17158462 147 9046 100 0.365 ± 0.187 0.621 ± 0.173 NC 
19 wsv415 gi|17158517 5 222 100 0.406 ± 0.164 0.670 ± 0.095 NC 
20 wsv421 gi|17158523 7 860 100 0.705 ± 0.243 0.137 ± 0.206 E 
21 wsv442 gi|17158543 6 305 100 0.695 ± 0.314 0.279 ± 0.496 E 
22 wssv349 gi|19481941 1 55 99.97 0.947 ± 0 0.125 ± 0 E 
23 wsv1983 gi|17158302 1 25 73.089 0.783 ± 0 0.141 ± 0 E 
24 wsv216 gi|17158320 1 30 91.91 0.758 ± 0  0.223 ± 0 E 
25 wsv230 gi|17158334 1 23 50.805 0.635 ± 0.120 0.294 ± 0.005 E 
26 wsv238 gi|17158342 1 29 88.961 0.553 ± 0.177 0.442 ± 0.029 E 
27 wsv242 gi|17158346 2 58 99.985 0.626 ± 0.144 0.179 ± 0.055 E 
28 wsv256 gi|17158359 1 27 81.296 0.532 ± 0.118 0.422 ± 0.023 E 
29 wsv289 gi|17158391 1 19 0 0.324 ± 0 0.683 ± 0 NC 
1 Avg, average; SD, standard deviation.  2 E, envelope and NC,  nucleocapsid. Structural proteins with previously 
unknown localization in WSSV were in bold.  3 WSSV proteins with the best peptide ion scores ≤ 30 are listed at the 
























No. TM1 PSORT2 
Location in 




Alternative Names & 
References 
1 wsv001 gi|17158634 TM N E   IEM WSSV-CLP (17) 
2 wsv002 gi|17158106 TM C E/T5 iTR WB IEM VP24 (23) 
3 wsv006 gi|17158110 TM N E iTR   this study 
4 wsv009 gi|17158113  C E iTR   this study 
5 wsv010 gi|17158114  N E  WB IEM this study 
6 wsv011 gi|17158115 TM C E iTR WB  VP53A (23) 
7 wsv021 gi|17158125 TM C E iTR   this study 
8 wsv035 gi|17158139 TM N E  WB IEM VP110 (22) 
9 wsv037 gi|17158141  N NC 1D   VP160B (23) 
10 wsv077 gi|17158181  C T  WB  VP36A (23) 
11 wsv115 gi|17158219 TM C E iTR   this study 
12 wsv143 gi|17158247  N NC iTR   this study 
13 wsv198 gi|17158302  C E iTR   this study 
14 wsv209 gi|17158313  N E iTR WB IEM VP187 (40) 
15 wsv214 gi|17158318  N NC  WB  VP15 (23) 
16 wsv216 gi|17158320  C E iTR WB IEM VP124 (19) 
17 wsv220 gi|17158324 TM C E  WB  VP674,VP73,VP76 (24) 
18 wsv230 gi|17158334  C E iTR   this study 
19 wsv237 gi|17158341  C E   IEM VP292 (16) 
20 wsv238 gi|17158342 TM C E iTR   this study 
21 wsv242 gi|17158346  C E iTR   this study 
22 wsv254 gi|17158357  C E iTR WB IEM VP281,VP36B (13,23) 
23 wsv256 gi|17158359 TM C E iTR WB  VP51B (23) 
24 wsv259 gi|17158362  N E iTR WB  VP38A (23) 
25 wsv271 gi|17158374  N NC iTR   this study 
26 wsv289 gi|17158391  N NC iTR,1D   VP160A (23) 
27 wsv295 gi|17158397  N E iTR   this study 
28 wsv306 gi|17158408  N E/T iTR WB  VP39A (23) 
29 wsv308 gi|17158410  N NC iTR,1D WB IEM VP466, VP51C (23) 
30 wsv311 gi|17158413 TM C E/T iTR WB IEM VP26 (15,23) 
31 wsv321 gi|17158423 TM N E iTR   this study 
32 wsv325 gi|17158427 TM N E iTR   this study 
33 wsv339 gi|17158441  N E  WB IEM VP39 (20) 
34 wsv340 gi|17158442  C E  WB IEM VP31 (18,23) 
35 wsv360 gi|17158462  N NC iTR,1D WB IEM VP664 (23,33) 
36 wsv386 gi|17158488 TM C E   IEM VP68 (16) 
37 wsv414 gi|17158516 TM C E  WB  VP19 (23,34) 
38 wsv415 gi|17158517  N NC iTR,1D WB  VP60B (23) 
39 wsv421 gi|17158523 TM C E iTR WB IEM VP28 (14,23) 
40 wsv432 gi|17158534  N E  WB IEM this study 
41 wsv442 gi|17158543  N E/T iTR WB  VP95 (23) 
42 wsv493 gi|17158594  N NC  WB  VP35 (6) 
43 wssv349 gi|19481941 TM C E iTR     this study 
1 TM, transmembrane domain.  2 N, nuclear; C, cytoplasmic.  3 E, envelope; T, tegument and NC, nucleocapsid.  4 iTR: detected 




5.3.4 Localization of Novel WSSV Structural Proteins by Western Blot Analysis and 
Immunogold Electron Microscopy Observation 
Western-blot analysis with the polyclonal anti-wsv010, wsv432 antibodies 
showed that wsv010 polyclonal antibody recognized the protein specifically in the whole 
virion and the viral envelope fraction, but not in the nucleocapsid fraction (Fig. 5.5 A, B).  
The localization of wsv010 and wsv432 on the envelope was further confirmed by IEM.  
It was observed that the gold particles were located on the surface of WSSV virions, 
while no gold particles could be found on the nucleocapsids with wsv010 polyclonal 
antibody (Fig. 5.6 A, B). When pre-immune rabbit serum was used as the primary 
antibody in the control experiment, no gold particles could be detected on WSSV virions 
(Fig. 5.6 C).  Wsv432 was also found to localize on virus envelope but not on the naked 


























Fig 5.5  Western blot analysis of the localization of wsv010 and wsv432 in WSSV 
 
Lane 1, total viral proteins; lane 2, envelope proteins; lane 3, nucleocapsid proteins.  A, 



















Fig 5.6  Localization of wsv010 in WSSV by IEM 
 
A, 0.1 % Tween 20 treated virus particles with the immunogold-labeled anti-wsv010 
antibody;  B, WSSV nucleocapsid detected with the anti-wsv010 antibody;  C, Virus 



















Fig 5.7  Localization of wsv432 in WSSV by IEM 
 A, WSSV with immunogold-labeled anti-wsv432 antibody; Insertion (a) shows another 








5.3.5 Protein-Protein Interaction Studies of Novel WSSV Structural Proteins 
Functions of novel wsv010 and wsv432 were studied by pull down assay and 
coimmunoprecipitation. But only pull down assay of wsv010 identified its interaction 
with major WSSV structural protein VP24 (wsv002). The recombinant wsv010 protein 
was used as a bait to pull down proteins from epithelial tissue of the healthy and the 
infected crayfish, respectively.  Eluted proteins were resolved by SDS-PAGE and 
followed by the silver staining.  A unique band was found in the eluted fraction of 
wsv010 with the infected epithelial tissue proteins (Fig. 5.8 A), but not in the bait control 
(wsv010 only) and the negative controls (epithelial tissue proteins only).  This band was 
identified as VP24 by mass spectrometry analysis (Table 5.4).  The interaction of wsv010 
with VP24 was further confirmed by Western blot analysis using the anti-VP24 


















Table 5.4 Measured and calculated molecular masses of tryptic peptides which match 





Start End Peptide Observed Mr(expt) Mr(calc) Delta 
38 58 DKDAYPVESEIINLTINGVAR 2317.23 2316.22 2316.20 0.02 
59 72 GNHFNFVNGTLQTR 1604.82 1603.81 1603.79 0.03 







Protein sequence of VP24 (Matched peptides are highlighted in bold) 
 
  1 MHMWGVYAAI LAGLTLILVV ISIVVTNIEL NKKLDKKDKD AYPVESEIIN 
 51 LTINGVARGN HFNFVNGTLQ TRNYGKVYVA GQGTSDSELV KRKGDIILTS 
101 LLGDGDHTLN VNKAXSKELE LYARVYNNTK RDITVDSVSL SPGLNATGRE 


























Fig 5.8 Pull down of VP24 by wsv010 
 
(A), Elution fractions of wsv010 pull-down assay.  Lanes: 1, molecular mass marker; lane 
2, the negative control 1 (infected epithelial tissue proteins only); lane 3, the negative 
control 2 (healthy epithelial tissue proteins only); lane 4, wsv010 with healthy epithelial 
tissue proteins; lane 5, wsv010 interacting with infected epithelial tissue proteins; 6, the 
bait control sample (wsv010 only).  (B), Western-blot analysis with the anti-VP24 
polyclonal antibody.  Lane 1, the wash fraction of wsv010 interacting with infected 
epithelial tissue proteins; lane 2, the elution fraction of wsv010 interacting with infected 
epithelial tissue proteins; and lane 3, the elution fraction of the negative control (infected 
epithelial tissue proteins only).  The molecular weight marker used was the Precision Plus 




5.4 Discussion and Conclusions 
Gel-based techniques have been successfully used to study the WSSV proteome 
and 38 viral structural proteins were identified in the past few years (Huang et al., 2002b; 
Tsai et al., 2004).  To further characterize the protein components of this virus, shotgun 
proteomics was applied and this has led to the identification of 45 structural proteins in 
our study, including 13 proteins that were identified for the first time.   
Totally 55 WSSV structural proteins were identified by the three proteomics 
studies and they are summarized in Fig. 5.9.  Among them, 17 proteins were uniquely 
identified by the LC-based approach, 10 were uniquely identified by the gel-based 
approach and 28 were identified by both, confirming the complementary nature of these 
two approaches.  Among the 17 proteins identified by shotgun proteomics, 4 structural 
proteins, including 2 envelope proteins VP187 (wsv209) and VP124 (wsv216), and 2 
nucleocapsid proteins, VP160B (wsv037) and VP160A (wsv289), have been identified by 
gel-based MS analyses in three recent publications (Li et al., 2006; Tsai et al., 2006; Zhu, 
Xie, and Yang, 2005).  However, four structural proteins VP1684 (wsv001), VP357 
(wsv129), VP184 (part of wsv303) and VP448 (wsv526) were only identified from 1D 
gel by MALDI-TOF peptide mass finger printing and could not be confirmed by MS/MS 
data, suggesting that these protein identifications are of low reliability and further 
evidences are needed to support these findings (Huang et al., 2002b).  Since only visible 
bands were excised from the gel, it is possible that those low abundant proteins might not 
be included in the gel based identification.  Comparatively, LC-based approach has an 
advantage in identifying low abundance proteins such as wsv230.  Moreover, several 
highly basic proteins, such as wsv021 (pI 9.35) and wsv324 (pI 9.3) were also identified 
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by the LC method.  Totally, 58 structural proteins have been identified in WSSV, 
including 55 proteins identified by shotgun and previous proteomics studies, one 
envelope protein wsv295 identified by our iTRAQ study and two nucleocapsid proteins 






























Fig 5.9.  A summary of WSSV structural proteins identified by proteomics studies  
WSSV structural proteins identified in the present study and two earlier reports were 
summarized.  * ORFs identified in other literatures as described in the discussion (Li et 
al., 2006; Tsai et al., 2006; Zhu, Xie, and Yang, 2005).  Underlined ORFs were also 
verified by the iTRAQ study.  ** Altogether, 58 structural proteins were identified, 
including 55 proteins identified by these three studies, wsv295 identified by iTRAQ, 





In the present study, quantitative MS analysis was introduced to discriminate viral 
envelope proteins and nucleocapsid proteins according to their distribution and 
localization.  As we expected, two distinct types of iTRAQ reporter ion spectras were 
achieved for envelope proteins and nucleocapsid proteins respectively (Fig. 5.4).  There 
are also some iTRAQ ratios (116/114) of nucleocapsid proteins were only slightly higher 
than that of 115/114 because of the presence of solubilized nucleocapsid proteins in the 
envelope fraction.  This is most likely due to partial dissociation of the nucleocapsid 
proteins caused by osmotic shock during the high salt treatment and the separation 
process (Durand et al., 1997; Tsai et al., 2006).  The localization results of structural 
proteins in the virion based on iTRAQ ratios are in good agreement with the previous 
investigations, including 11 envelope proteins and 4 nucleocapsid proteins (Li et al., 2006; 
Tsai et al., 2006; Zhu, Xie, and Yang, 2005).  Seven newly characterized proteins contain 
predicted transmembrane domains, supporting their classification as envelope proteins 
(Table 5.3).  Our data demonstrated the feasibility of accurate localization of viral 
structural proteins by the iTRAQ approach, even though contaminant-free fractions could 
not be obtained.  The ability of distinguishing envelope and nucleocapsid proteins 
without the need of complete separation represents a significant advance in the 
localization of viral structural proteins. This approach should also be applicable to study 
the protein localization of other enveloped viruses.  In summary, WSSV is composed of 
at least 58 structural proteins including 13 viral proteins identified by shotgun proteomics 
and 1 by iTRAQ in this study.  Among these structural proteins, the localization of 34 
envelope proteins and 9 nucleocapsid proteins were determined. Among them, 12 
envelope proteins and 2 nucleocapsid proteins were identified by our iTRAQ study.  This 
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study could provide new information for investigation of the molecular mechanisms of 
virus assembly and virus entry. 
Among the novel structural proteins, the localizations of wsv010 and wsv432 
were confirmed by routine western blot analysis and IEM technique. The pull-down 
assay of wsv010 showed the interaction of wsv010 with VP24. This result suggests that 
the association of wsv010 with VP24 either directly or indirectly may allow wsv010 to 
anchor to the envelope.  A previous study indicated that VP24 could also interact with 
important structural proteins VP28 and VP26 to form a complex that plays a role in virus 
infection (Xie and Yang, 2006).  Thus, we postulate that VP24 may play a role as a linker 
protein to link up the structural proteins VP28, VP26, wsv010, and probably other 
envelope proteins, to form a complex on the viral envelope.  The possibility of existence 
of this complex will be tested in future study.  Since both VP26 and VP28 are important 
for virus infection, it will be interesting to determine if wsv010 is also critical for virus 
entry.  The characterization of the interaction of wsv010 with VP24 will enrich our 









































Due to the low homology of WSSV genome with other genes of known functions 
and the lack of a suitable shrimp cell line, we applied protein array platform for high-
throughput screening of WSSV protein functions and proteomics approaches for 
investigation of the WSSV structural proteins.   
Firstly, Gateway cloning technique was applied to construct entry and expression 
clones of the ORFs of WSSV in a high-throughput format.  Entry clones of nearly all the 
WSSV ORFs were constructed and sequenced. Expression clones of most WSSV ORFS 
for E. coli expression system were constructed. Totally 65 WSSV proteins were 
expressed as soluble proteins and 45 were expressed as insoluble proteins by western 
blotting identification. The recombinant proteins expressed as soluble proteins and the 
recombinant proteins expressed as insoluble proteins containing few cysteine residues 
were chosen for large scale culture and purification. Several recombinant WSSV proteins 
were produced with high yield and purity.  But many of the recombinant WSSV proteins 
were poorly produced.  Until now, 33 purified proteins were obtained and 20 of them 
were purified as soluble proteins. Except wsv146, wsv321 and wsv386, all of the purified 
proteins were confirmed by MALDI-TOF mass spectrometry analysis.  
To understand the mechanism of the virus infection, it is very important to study 
the interactions of virus proteins with host proteins. The purified recombinant WSSV 
proteins were used for protein array experiments to screen potential virus-host protein-
protein interactions. Potential interactions of WSSV proteins with actin, shrimp 
cytoskeleton and nuclear proteins were screened in this study. The result of protein array 
probed with actin showed that wsv006, wsv077, wsv254, wsv407, wsv477 and wsv076 
have binding signal with actin. The interaction of wsv006 with actin was confirmed by 
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protein overlay assay and the interaction of wsv254 with actin was confirmed by co-
immmunoprecipitation. By interacting with actin, both of the structural proteins may help 
the viral nucleocapsid to move toward the host nucleus. From the protein array results 
probed with shrimp cytoskeleton and nuclear proteins, several WSSV proteins were 
found to interact with shrimp cytoskeleton and nuclear proteins separately. Pull down 
assay of wsv254, wsv407 with shrimp cytoskeleton proteins and wsv254, wsv493 with 
shrimp nuclear proteins were carried out, but no specific binding was found. The 
interaction conditions for pull down assay will be optimized and other protein-protein 
interaction methods will be applied to validate the protein array results.  
Meantime, we applied shotgun proteomics using offline coupling of LC system 
with MALDI TOF/TOF MS/MS to investigate the WSSV proteome.  By this approach, 
45 structural proteins were identified and 13 of them were reported for the first time.  
Furthermore, iTRAQ was employed to distinguish WSSV envelope proteins and 
nucleocapsid proteins.  Based on iTRAQ ratios, 23 envelope proteins and 6 nucleocapsid 
proteins were successfully identified.  Our results validated 15 structural proteins with 
previously known localization and determined localization of additional 12 envelope 
proteins and 2 nucleocapsid proteins.  iTRAQ was demonstrated to be an effective 
approach for high-throughput viral protein localization determination.  In summary, 
WSSV was assembled by at least 58 structural proteins.  The localization of 43 structural 
proteins has been determined, 34 of which were envelope proteins and 9 as nucleocapsid 
proteins.   
Two novel proteins wsv010 and wsv432 identified in the shotgun proteomics 
study were shown to be viral envelope proteins by western blotting and IEM technology.  
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Furthermore, the pull-down assay revealed that wsv010 could interact with VP24, which 
is a major WSSV envelope protein.  Since wsv010 lacks a transmembrane domain, these 
results suggest that wsv010 may anchor to the envelope through interaction with VP24.  
Previous studies indicated that VP24 could also interact with another two major WSSV 
structural proteins VP26 (wsv311) and VP28 (wsv421) (Xie, Xu, and Yang, 2006; Xie 
and Yang, 2006).  Therefore, we proposed that VP24 may act as a linker protein to 
associate these envelope proteins together to form a complex, which may play an 
important role in viral morphogenesis and viral infection.  
In conclusion, protein array of WSSV proteins will be continuously applied to 
analyze virus protein-protein interactions, virus-host protein-protein interactions. It can 
also be used to screen interactions with small molecules or peptides to identify potential 
inhibitors (Kuruvilla et al., 2002). Combined with the WSSV proteome knowledge, it 
should facilitate the studies of the WSSV assembly and mechanism of infection and may 
lead to the development of inhibitors of virus entry, replication, or movement. Based on 
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Media and solutions 
LB broth (per liter) 
 
To 950 mL of MQ H2O, add: 
Bacto-tryptone 10 g 
Bacto-yeast extract 5 g 
NaCl   10 g 
 
Dissolve solutes. Adjust pH to 7.0 with 1 M NaOH. Adjust volume to 1L with 
MQ H2O. Sterilize by autoclaving. 
 
SOC medium (per liter) 
 
To 950 mL of MQ H2O, add: 
Bacto-tryptone 20 g 
Bacto-yeast extract 5 g 
NaCl   0.58 g 
 
Dissolve solutes. Add 10 mL of 250 mM KCl. Adjust pH to 7.0 with 1 M NaOH. 
Adjust volume to 980 mL with MQ water. Sterilize by autoclaving. Allow to cool to 
60°C or less, and then add 20 mL of sterile 1M glucose. Add 10 mL of sterile 1 M MgCl2 
just prior to use. 
 
Tfb I (per liter) 
 
To 950 mL of MQ H2O, add: 
CH3COOK  2.94 g 
RbCl   12.1 g 
CaCl2·2H2O  14.7 g 
MnCl2·4H2O  9.9 g 
Glycerol  150 mL 
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Adjust pH to 5.8 with dilute acetic acid, add MQ H2O to 1 L and autoclave. 
 
Tfb II (per liter) 
 
To 950 mL of MQ H2O, add: 
MOPS   2.1 g 
CaCl2   11.1 g 
RbCl   1.21 g 
Glycerol  150 mL 
 
Adjust pH to 6.5 with 1 M NaOH, add MQ H2O to 1 L and autoclave. 
 
Kits 
Compartmental protein extraction Kit                        Chemicon 
PCR Cloning System with Gateway Technology       Invitrogen 
QIAquick PCR purification kit   QIAGEN  
QIAprep spin miniprep kit    QIAGEN 
QIAquick gel extraction kit    QIAGEN 
BigDye® terminator v3.1 cycle sequencing kit Applied Biosystems 




High Speed Centrifuge     Beckman, J2-21 
Ultracentrifuge      Beckman, XL-90 
MicroPulser® Electroporator      Bio-Rad 
Thermal Cycler      Bio-Rad 
ABI PRISM™ 3100 Genetic Analyzer  Applied Biosystems 
Voyager-DE™ STR BioSpectrometry Workstation  Applied Biosystems 
4700 Proteomics Analyzer with TOF/TOF™ optics  Applied Biosystems 
Ultimate™ LC system     Dionex LC Packings 
Typhoon 9410 instrument                                                       Amersham Bioscience 
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